| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication | 
|---|
| D000074 | Acenocoumarol | APOE gene polymorphism affects the susceptibility to Acenocoumarol | affects response to substance | 15861030 
 | 
| D000082 | Acetaminophen | Acetaminophen affects the expression of APOE protein | affects expression | 16099942 
 | 
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of APOE protein | decreases expression | 16687475 
 | 
| D000109 | Acetylcholine | APOE protein affects the susceptibility to Acetylcholine | affects response to substance | 17899169 
 | 
| D000171 | Acrolein | Acrolein affects the folding of APOE protein | affects folding | 17580963 
 | 
| D000171 | Acrolein | Acrolein results in decreased activity of APOE protein | decreases activity | 17580963 
 | 
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of APOE protein | affects expression | 20106945 
 | 
| C096920 | AGN 193109 | AGN 193109 inhibits the reaction [Tretinoin results in increased expression of APOE mRNA] | decreases reaction|increases expression | 16505366 
 | 
| D013196 | Dihydrotestosterone | APOE gene polymorphism affects the reaction [Dihydrotestosterone affects the phosphorylation of MAPK10 protein] | affects phosphorylation|affects reaction | 17395708 
 | 
| D013196 | Dihydrotestosterone | APOE gene polymorphism affects the reaction [Dihydrotestosterone affects the phosphorylation of MAPK9 protein] | affects phosphorylation|affects reaction | 17395708 
 | 
| D013196 | Dihydrotestosterone | APOE gene polymorphism affects the susceptibility to Dihydrotestosterone | affects response to substance | 17395708 
 | 
| C061621 | alpha-naphthyl isocyanate | alpha-naphthyl isocyanate affects the expression of APOE protein | affects expression | 16099942 
 | 
| D000638 | Amiodarone | Amiodarone results in decreased expression of APOE mRNA | decreases expression | 17991464 
 | 
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of APOE mRNA | affects expression | 16483693 
 | 
| D001151 | Arsenic | APOE polymorphism results in increased susceptibility to Arsenic | increases response to substance | 18022660 
 | 
| C065179 | atorvastatin | [Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with atorvastatin co-treated with valsartan] results in decreased expression of APOE protein | affects cotreatment|decreases expression | 19603250 
 | 
| D001629 | Bezafibrate | [Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with atorvastatin co-treated with valsartan] results in decreased expression of APOE protein | affects cotreatment|decreases expression | 19603250 
 | 
| C053342 | brevetoxin | brevetoxin analog results in decreased expression of APOE mRNA | decreases expression | 14529743 
 | 
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of APOE mRNA | increases expression | 15336504 
 | 
| D002118 | Calcium | APOE protein affects the abundance of Calcium | affects abundance | 17899169 
 | 
| D002118 | Calcium | Calcium affects the expression of APOE mRNA | affects expression | 15913539 
 | 
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of APOE protein | increases expression | 16845489 
 | 
| D002784 | Cholesterol | APOE protein affects the susceptibility to Cholesterol | affects response to substance | 16179587 
 | 
| D002791 | Cholesterol, Dietary | [Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 19509184 
 | 
| D008076 | Cholesterol, HDL | APOE gene polymorphism affects the abundance of Cholesterol, HDL | affects abundance | 16030523 
 | 
| D003520 | Cyclophosphamide | Cyclophosphamide results in decreased expression of APOE mRNA | decreases expression | 15331540 
 | 
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of APOE mRNA | decreases expression | 20106945 
 | 
| C017160 | cypermethrin | cypermethrin results in decreased expression of APOE mRNA | decreases expression | 9650644 11428908
 
 | 
| D004041 | Dietary Fats | [Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 19509184 
 | 
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of APOE mRNA | decreases expression | 18042831 
 | 
| D004052 | Diethylnitrosamine | [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of APOE protein | affects cotreatment|increases expression | 20935162 
 | 
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of APOE mRNA | increases expression | 15766595 
 | 
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in decreased expression of APOE mRNA | decreases expression | 15171707 
 | 
| D004176 | Dipyridamole | [Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with atorvastatin co-treated with valsartan] results in decreased expression of APOE protein | affects cotreatment|decreases expression | 19603250 
 | 
| D004656 | Enalapril | [Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with atorvastatin co-treated with valsartan] results in decreased expression of APOE protein | affects cotreatment|decreases expression | 19603250 
 | 
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of APOE mRNA | affects expression | 17555576 
 | 
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of APOE mRNA | decreases expression | 14976129 16174780
 17942748
 
 | 
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 17942748 
 | 
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of APOE mRNA | decreases expression | 17351261 17557909
 
 | 
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of APOE mRNA | increases expression | 16174780 
 | 
| D015025 | Zearalenone | Zearalenone results in decreased expression of APOE mRNA | decreases expression | 19371625 
 | 
| D005632 | Fructose | [Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 19509184 
 | 
| C100093 | gentamicin C | APOE protein inhibits the reaction [gentamicin C results in decreased expression of and results in decreased activity of SLC5A1 protein] | decreases activity|decreases expression|decreases reaction | 15777622 
 | 
| C100093 | gentamicin C | APOE protein inhibits the reaction [gentamicin C results in decreased expression of SLC5A1 mRNA] | decreases expression|decreases reaction | 15777622 
 | 
| C100093 | gentamicin C | APOE protein results in decreased uptake of gentamicin C | decreases uptake | 15777622 
 | 
| C473027 | GW 3965 | GW 3965 results in increased expression of APOE mRNA | increases expression | 17449538 
 | 
| C029424 | hydrazine | hydrazine results in decreased expression of APOE mRNA | decreases expression | 15370871 
 | 
| C029424 | hydrazine | hydrazine results in decreased expression of APOE protein | decreases expression | 15370871 
 | 
| D000960 | Hypolipidemic Agents | Hypolipidemic Agents results in decreased expression of APOE protein | decreases expression | 19603250 
 | 
| D007501 | Iron | APOE gene polymorphism results in increased susceptibility to Iron | increases response to substance | 15993987 
 | 
| D007657 | Ketone Bodies | Ketone Bodies results in increased expression of APOE mRNA | increases expression | 16807920 
 | 
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of APOE mRNA | decreases expression | 16847310 
 | 
| C029938 | nickel sulfate | nickel sulfate results in decreased expression of APOE mRNA | decreases expression | 16780908 
 | 
| C029938 | nickel sulfate | nickel sulfate results in increased expression of APOE mRNA | increases expression | 16780908 
 | 
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in decreased expression of APOE mRNA | decreases expression | 17616710 
 | 
| D010126 | Ozone | Ozone results in decreased expression of APOE mRNA | decreases expression | 12763052 
 | 
| C041786 | palm oil | palm oil results in decreased expression of APOE mRNA | decreases expression | 18042831 
 | 
| C084656 | paricalcitol | [Phosphorus co-treated with paricalcitol] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 17715259 
 | 
| D010634 | Phenobarbital | Phenobarbital affects the expression of APOE protein | affects expression | 16099942 
 | 
| D010634 | Phenobarbital | [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of APOE protein | affects cotreatment|increases expression | 20935162 
 | 
| D010656 | Phenylephrine | APOE protein affects the susceptibility to Phenylephrine | affects response to substance | 17899169 
 | 
| D010672 | Phenytoin | Phenytoin results in increased expression of APOE mRNA | increases expression | 15136057 
 | 
| D010758 | Phosphorus | [Phosphorus co-treated with paricalcitol] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 17715259 
 | 
| D010840 | Phytosterols | APOE gene mutant form affects the reaction [Phytosterols results in increased expression of CYP51 mRNA] | affects reaction|increases expression | 18155511 
 | 
| D010840 | Phytosterols | APOE gene mutant form affects the reaction [Phytosterols results in increased expression of CYP7B1 mRNA] | affects reaction|increases expression | 18155511 
 | 
| D010840 | Phytosterols | APOE gene mutant form affects the reaction [Phytosterols results in increased expression of FADS1 mRNA] | affects reaction|increases expression | 18155511 
 | 
| D010840 | Phytosterols | APOE gene mutant form affects the reaction [Phytosterols results in increased expression of FADS2 mRNA] | affects reaction|increases expression | 18155511 
 | 
| D010840 | Phytosterols | APOE gene mutant form affects the reaction [Phytosterols results in increased expression of HMGCR mRNA] | affects reaction|increases expression | 18155511 
 | 
| D010840 | Phytosterols | APOE gene mutant form affects the reaction [Phytosterols results in increased expression of HMGCS1 mRNA] | affects reaction|increases expression | 18155511 
 | 
| D010840 | Phytosterols | APOE gene mutant form affects the reaction [Phytosterols results in increased expression of HSD17B7 mRNA] | affects reaction|increases expression | 18155511 
 | 
| D010840 | Phytosterols | APOE gene mutant form affects the reaction [Phytosterols results in increased expression of LPIN1 mRNA] | affects reaction|increases expression | 18155511 
 | 
| D010840 | Phytosterols | APOE gene mutant form affects the reaction [Phytosterols results in increased expression of PPARGC1B mRNA] | affects reaction|increases expression | 18155511 
 | 
| D010840 | Phytosterols | APOE gene mutant form affects the reaction [Phytosterols results in increased expression of SQLE mRNA] | affects reaction|increases expression | 18155511 
 | 
| C006253 | pirinixic acid | pirinixic acid affects the expression of APOE protein | affects expression | 16099942 
 | 
| C025299 | polyphenols | polyphenols results in decreased expression of APOE protein | decreases expression | 16046716 
 | 
| D011794 | Quercetin | Quercetin results in increased expression of APOE mRNA | increases expression | 16455785 
 | 
| C059514 | resveratrol | resveratrol results in increased expression of APOE mRNA | increases expression | 19371625 
 | 
| C009166 | retinol acetate | retinol acetate results in increased expression of APOE mRNA | increases expression | 16772331 
 | 
| D012643 | Selenium | Selenium results in increased expression of APOE mRNA | increases expression | 19244175 
 | 
| D012643 | Selenium | Selenium affects the expression of APOE protein | affects expression | 17996733 
 | 
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of APOE mRNA | decreases expression | 19822182 
 | 
| D013311 | Streptozocin | Streptozocin results in increased expression of APOE mRNA | increases expression | 16684804 
 | 
| D013311 | Streptozocin | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of APOE mRNA] | decreases reaction|increases expression | 16684804 
 | 
| D013629 | Tamoxifen | APOE gene polymorphism affects the susceptibility to Tamoxifen | affects response to substance | 19103187 
 | 
| D013629 | Tamoxifen | Tamoxifen affects the expression of APOE mRNA | affects expression | 17555576 
 | 
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of APOE mRNA | increases expression | 20106945 
 | 
| D013749 | Tetrachlorodibenzodioxin | APOE protein affects the susceptibility to Tetrachlorodibenzodioxin | affects response to substance | 12213967 
 | 
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 17942748 
 | 
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of APOE mRNA | decreases expression | 15703262 
 | 
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of APOE mRNA | increases expression | 16267337 
 | 
| C423915 | TO-901317 | TO-901317 results in increased expression of APOE mRNA | increases expression | 17449538 
 | 
| C423915 | TO-901317 | TO-901317 results in increased expression of APOE mRNA | increases expression | 19665519 
 | 
| C024746 | tobacco tar | tobacco tar results in decreased expression of APOE mRNA | decreases expression | 19559774 
 | 
| C066340 | tolcapone | tolcapone binds to APOE protein | affects binding | 19783845 
 | 
| D014212 | Tretinoin | AGN 193109 inhibits the reaction [Tretinoin results in increased expression of APOE mRNA] | decreases reaction|increases expression | 16505366 
 | 
| D014212 | Tretinoin | Tretinoin results in increased expression of APOE mRNA | increases expression | 16505366 
 | 
| D014331 | Tropicamide | APOE gene polymorphism results in increased susceptibility to Tropicamide | increases response to substance | 8724673 9137131
 
 | 
| C081489 | valsartan | [Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with atorvastatin co-treated with valsartan] results in decreased expression of APOE protein | affects cotreatment|decreases expression | 19603250 
 | 
| C081489 | valsartan | valsartan inhibits the reaction [AGT protein results in decreased expression of APOE protein] | decreases expression|decreases reaction | 17785354 
 | 
| C034028 | vanadyl sulfate | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of APOE mRNA] | decreases reaction|increases expression | 16684804 
 | 
| D014812 | Vitamin K | APOE protein affects the abundance of Vitamin K | affects abundance | 15952022 
 | 
| D014812 | Vitamin K | APOE protein affects the uptake of Vitamin K | affects uptake | 16847429 
 | 
| D014859 | Warfarin | APOE gene polymorphism affects the susceptibility to Warfarin | affects response to substance | 17325732 16847429
 17048007
 
 | 
| D014859 | Warfarin | APOE protein affects the susceptibility to Warfarin | affects response to substance | 15952022 
 | 
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication | 
|---|
| MESH:D000008 | Abdominal Neoplasms |  | Tamoxifen | 3.86 | 14745880 | 
| MESH:D000014 | Abnormalities, Drug-Induced |  | Phenobarbital | 10.49 | 6195326 | 
| MESH:D000014 | Abnormalities, Drug-Induced |  | Phenytoin | 10.49 | 10563481	9677735	6195326	8986270	3425630	9118846 | 
| MESH:D000014 | Abnormalities, Drug-Induced |  | Tetrachlorodibenzodioxin | 10.49 | 11752688	15322242	14514962 | 
| MESH:D000138 | Acidosis |  | Ammonium Chloride | 2.89 | 18287403 | 
| MESH:D000152 | Acne Vulgaris |  | Ethinyl Estradiol | 3.26 | 17505938 | 
| MESH:D058186 | Acute Kidney Injury |  | resveratrol | 3.26 | 16538975 | 
| MESH:D055371 | Acute Lung Injury |  | Acrolein | 16.75 | 21297076	20525806 | 
| MESH:D055371 | Acute Lung Injury |  | Lipopolysaccharides | 16.75 | 18653653	11850527 | 
| MESH:D055371 | Acute Lung Injury |  | nickel sulfate | 16.75 | 16100012	19131640	12718980	11954676 | 
| MESH:D055371 | Acute Lung Injury |  | pirinixic acid | 16.75 | 18653653 | 
| MESH:D000230 | Adenocarcinoma |  | Ethinyl Estradiol | 1.62 | 14692618 | 
| MESH:D000236 | Adenoma |  | Diethylnitrosamine | 5.45 | 6695378	10737359 | 
| MESH:D000236 | Adenoma |  | resveratrol | 5.45 | 15688382 | 
| MESH:D018248 | Adenoma, Liver Cell |  | Diethylnitrosamine | 19.38 | 19061943	16434500	17620307	17162532	19052882	18056438 | 
| MESH:D018248 | Adenoma, Liver Cell |  | Phenobarbital | 19.38 | 17620307 | 
| MESH:D018248 | Adenoma, Liver Cell |  | pirinixic acid | 19.38 | 16434500 | 
| MESH:D018248 | Adenoma, Liver Cell |  | Tetrachlorodibenzodioxin | 19.38 | 16835633 | 
| MESH:D000310 | Adrenal Gland Neoplasms |  | sodium arsenite | 4.01 | 15276417 | 
| MESH:D018246 | Adrenocortical Adenoma |  | Arsenic | 11.52 | 17306315 | 
| MESH:D018246 | Adrenocortical Adenoma |  | sodium arsenite | 11.52 | 17306315	16712894 | 
| MESH:D000382 | Agricultural Workers' Diseases |  | cypermethrin | 4.27 | 16487989 | 
| MESH:D017109 | Akathisia, Drug-Induced |  | tolcapone | 5.61 | 11080934 | 
| MESH:D000505 | Alopecia |  | Tretinoin | 3.07 | 15955085 | 
| MESH:D019896 | alpha 1-Antitrypsin Deficiency |  | Iron | 4.98 | 16640825 | 
| MESH:D000544 | Alzheimer Disease | marker/mechanism |  |  | 19734902 | 
| MESH:D000544 | Alzheimer Disease |  | Acrolein | 13.14 | 14715435	17570602	15207723 | 
| MESH:D000544 | Alzheimer Disease |  | Cholesterol, Dietary | 13.14 | 20157255 | 
| MESH:D000544 | Alzheimer Disease |  | Iron | 13.14 | 16640825	16563566 | 
| MESH:D000544 | Alzheimer Disease |  | Ozone | 13.14 | 15513908 | 
| MESH:D000544 | Alzheimer Disease |  | resveratrol | 13.14 | 16162502	16183991 | 
| MESH:D000544 | Alzheimer Disease |  | tolcapone | 13.14 | 20150427 | 
| MESH:C536595 | Alzheimer disease type 2 | marker/mechanism |  |  |  | 
| MESH:D000686 | Amyloidosis | marker/mechanism |  |  | 15993987 | 
| MESH:D000686 | Amyloidosis |  | Diethylstilbestrol | 3.84 | 15469931 | 
| MESH:D000740 | Anemia |  | Iron | 6.97 | 16434484	16566752 | 
| MESH:D000740 | Anemia |  | Tetrachlorodibenzodioxin | 6.97 | 11748828 | 
| MESH:D000743 | Anemia, Hemolytic |  | Quercetin | 3.63 | 17084956 | 
| MESH:D018798 | Anemia, Iron-Deficiency |  | Iron | 4.06 | 17375513	16569441	17163184	17162259	17147795 | 
| MESH:D000756 | Anemia, Sideroblastic |  | Iron | 4.20 | 16910769 | 
| MESH:D000799 | Angioedema |  | Acetaminophen | 3.16 | 10982225 | 
| MESH:D001145 | Arrhythmias, Cardiac |  | Amiodarone | 11.66 | 18057881	20041841	18218290 | 
| MESH:D001145 | Arrhythmias, Cardiac |  | Iron | 11.66 | 16604332 | 
| MESH:D001145 | Arrhythmias, Cardiac |  | Phenylephrine | 11.66 | 17460149 | 
| MESH:D020261 | Arsenic Poisoning |  | Arsenic | 2.64 | 16835338	16251483	18414634	12569548 | 
| MESH:D001161 | Arteriosclerosis |  | Acrolein | 25.06 | 15014928 | 
| MESH:D001161 | Arteriosclerosis |  | Cholesterol, Dietary | 25.06 | 15552841 | 
| MESH:D001161 | Arteriosclerosis |  | Cyclophosphamide | 25.06 | 15014928 | 
| MESH:D001161 | Arteriosclerosis |  | Dietary Fats | 25.06 | 15238619 | 
| MESH:D001161 | Arteriosclerosis |  | Ethinyl Estradiol | 25.06 | 11256880 | 
| MESH:D001169 | Arthritis, Experimental |  | Ethinyl Estradiol | 9.66 | 15885639 | 
| MESH:D001169 | Arthritis, Experimental |  | resveratrol | 9.66 | 17115116 | 
| MESH:D001169 | Arthritis, Experimental |  | Tretinoin | 9.66 | 16412693 | 
| MESH:D001172 | Arthritis, Rheumatoid |  | Ozone | 3.96 | 15570426 | 
| MESH:D001172 | Arthritis, Rheumatoid |  | Tretinoin | 3.96 | 16292516 | 
| MESH:D001249 | Asthma |  | Ozone | 4.08 | 17854713	16373670 | 
| MESH:D001249 | Asthma |  | Tretinoin | 4.08 | 16456186 | 
| MESH:D001260 | Ataxia Telangiectasia |  | Iron | 10.88 | 15336622 | 
| MESH:D001260 | Ataxia Telangiectasia |  | Quercetin | 10.88 | 15336622 | 
| MESH:D050197 | Atherosclerosis | marker/mechanism |  |  | 9169506 | 
| MESH:D050197 | Atherosclerosis |  | Acrolein | 20.06 | 16126721	16037261	17363696 | 
| MESH:D050197 | Atherosclerosis |  | Arsenic | 20.06 | 12928151	19371607 | 
| MESH:D050197 | Atherosclerosis |  | Cholesterol | 20.06 | 16632123 | 
| MESH:D050197 | Atherosclerosis |  | Iron | 20.06 | 16640825	16632123 | 
| MESH:D050197 | Atherosclerosis |  | Phenytoin | 20.06 | 15136057 | 
| MESH:D050197 | Atherosclerosis |  | resveratrol | 20.06 | 16873680	17967414 | 
| MESH:D001281 | Atrial Fibrillation |  | Amiodarone | 3.38 | 18651412	19698954 | 
| MESH:D001321 | Autistic Disorder |  | Acetaminophen | 2.16 | 18445737 | 
| MESH:D001321 | Autistic Disorder |  | Iron | 2.16 | 17352947 | 
| MESH:D001327 | Autoimmune Diseases |  | Quercetin | 3.75 | 19761891 | 
| MESH:D001424 | Bacterial Infections |  | Iron | 4.52 | 16640825 | 
| MESH:D001471 | Barrett Esophagus |  | Tretinoin | 3.76 | 16935849 | 
| MESH:D001778 | Blood Coagulation Disorders |  | Amiodarone | 17.01 | 19483382 | 
| MESH:D001778 | Blood Coagulation Disorders |  | pirinixic acid | 17.01 | 19483382 | 
| MESH:D001778 | Blood Coagulation Disorders |  | Tetrachlorodibenzodioxin | 17.01 | 12125929 | 
| MESH:D001778 | Blood Coagulation Disorders |  | Tretinoin | 17.01 | 16206674	16197459 | 
| MESH:D001836 | Body Weight Changes |  | Tetrachlorodibenzodioxin | 3.11 | 15340226 | 
| MESH:D001848 | Bone Diseases, Developmental |  | Tetrachlorodibenzodioxin | 2.30 | 15746008 | 
| MESH:D001919 | Bradycardia |  | Phenylephrine | 3.88 | 15306635 | 
| MESH:D002545 | Brain Ischemia |  | resveratrol | 3.62 | 17600658 | 
| MESH:D001943 | Breast Neoplasms |  | Cyclophosphamide | 4.84 | 18234424	15093573	17388661	15136595	11325840	16978400	17020986	12006526	18323546 | 
| MESH:D001943 | Breast Neoplasms |  | Dietary Fats | 4.84 | 20435547 | 
| MESH:D001943 | Breast Neoplasms |  | Diethylnitrosamine | 4.84 | 17474063 | 
| MESH:D001943 | Breast Neoplasms |  | Diethylstilbestrol | 4.84 | 17129689	15324884 | 
| MESH:D001943 | Breast Neoplasms |  | Quercetin | 4.84 | 18628248 | 
| MESH:D001943 | Breast Neoplasms |  | resveratrol | 4.84 | 17651959	17534123	16393696 | 
| MESH:D001943 | Breast Neoplasms |  | Tamoxifen | 4.84 | 17242785	15565566	16818667	17049068	19155303	15668708	20065188	19011961	20135344	19221464	18821012	19142967	18629630	20544844	19066611	18815881	18351453	16202921	19289846	19189212	18425577	19115204	11161223	19084267	18997820	16873071	18855134	17440819	19103187	17893378	19200415	19189210	19244106	19410462	21152245	21138602	17261762	19487384	20390343	20005174	18984771	19059307	20859285	19288272	16273361 | 
| MESH:D001943 | Breast Neoplasms |  | Tetrachlorodibenzodioxin | 4.84 | 20435547 | 
| MESH:D001943 | Breast Neoplasms |  | Tretinoin | 4.84 | 16443354	16873071	16166294 | 
| MESH:D016535 | Bronchial Hyperreactivity |  | Ozone | 3.14 | 18417511	19059883	15516495	16777450	18315731	14754758	17626835 | 
| MESH:D001997 | Bronchopulmonary Dysplasia |  | Tretinoin | 3.92 | 16813970 | 
| MESH:D002100 | Cachexia |  | Ozone | 4.07 | 16183385 | 
| MESH:D002105 | Cadmium Poisoning |  | Quercetin | 4.86 | 16962696 | 
| MESH:D002252 | Carbon Tetrachloride Poisoning |  | Carbon Tetrachloride | 3.13 | 18705752	16050911	3786805	15700767	10355542	15673190	16097048	16227642	16124888	16192424	16011737	15721981 | 
| MESH:D002276 | Carcinoid Tumor |  | Streptozocin | 4.92 | 16051944 | 
| MESH:D002277 | Carcinoma |  | Tetrachlorodibenzodioxin | 2.26 | 16835633 | 
| MESH:D002280 | Carcinoma, Basal Cell |  | Arsenic | 3.17 | 15504454	17687452 | 
| MESH:D018270 | Carcinoma, Ductal, Breast |  | Tamoxifen | 3.85 | 19066611 | 
| MESH:D018236 | Carcinoma, Embryonal |  | Tretinoin | 4.47 | 16168501 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Acetaminophen | 31.31 | 3084413 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Aflatoxin B1 | 31.31 | 12907637	12619106	21507988 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Arsenic | 31.31 | 16507464	17306315 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Carbon Tetrachloride | 31.31 | 18788625 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Cyclophosphamide | 31.31 | 19701751 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Diethylnitrosamine | 31.31 | 20727157	20524982	18393292	17428255	19539802	16779866	16328049	16288022	16502159	11831363	19208518	19171122	3084413	19822196	17055752	17978847	19701751	17173139	17761372	17138121	18210153	20007298	16935385	20935162	20214788	18506893	19052882	21159647	16569478	20512989	18494052	19394651	10672840	19107877	20514400	18691550	18785209	18056438	20084675	3581430	16807293	16698587	16681979	19418558	19919837	17162532	18971187	19383236	20101231	10737359	18978308	18665156	19519916	16540662	16878318	16830150	20432363	19335982	18788625 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Diethylstilbestrol | 31.31 | 16924424	15948411 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Phenobarbital | 31.31 | 20935162	1701930	6705139	17173139	20007298 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Quercetin | 31.31 | 19519916	12508355 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | resveratrol | 31.31 | 19321006	16227395 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | sodium arsenite | 31.31 | 17306315	15276417	16507464 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Tamoxifen | 31.31 | 16924424 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Tretinoin | 31.31 | 1917145 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Vitamin K | 31.31 | 16328049 | 
| MESH:D018827 | Carcinoma, Lewis Lung |  | Cyclophosphamide | 9.26 | 16152834 | 
| MESH:D018827 | Carcinoma, Lewis Lung |  | resveratrol | 9.26 | 16675471 | 
| MESH:D021441 | Carcinoma, Pancreatic Ductal |  | Quercetin | 4.30 | 17234771 | 
| MESH:D002292 | Carcinoma, Renal Cell |  | Cyclophosphamide | 3.18 | 16201981 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | Arsenic | 8.72 | 15504454	18922899	17687452 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | resveratrol | 8.72 | 16227395 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | sodium arsenite | 8.72 | 18572023 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | Tretinoin | 8.72 | 16051514	16096774 | 
| MESH:D002295 | Carcinoma, Transitional Cell |  | Arsenic | 7.54 | 18640142 | 
| MESH:D002295 | Carcinoma, Transitional Cell |  | Tamoxifen | 7.54 | 17572228 | 
| MESH:D006332 | Cardiomegaly |  | atorvastatin | 17.10 | 18360054 | 
| MESH:D006332 | Cardiomegaly |  | Phenylephrine | 17.10 | 15728586	11754973	17124262	17287366	11179087	16170337 | 
| MESH:D006332 | Cardiomegaly |  | Quercetin | 17.10 | 19794523 | 
| MESH:D006332 | Cardiomegaly |  | Tetrachlorodibenzodioxin | 17.10 | 18670907	18850075	16120746 | 
| MESH:D006332 | Cardiomegaly |  | valsartan | 17.10 | 19597038 | 
| MESH:D009202 | Cardiomyopathies |  | Iron | 6.93 | 16640825 | 
| MESH:D009202 | Cardiomyopathies |  | valsartan | 6.93 | 16247790 | 
| MESH:D002311 | Cardiomyopathy, Dilated |  | Amiodarone | 5.21 | 15710769	19225199 | 
| MESH:D002311 | Cardiomyopathy, Dilated |  | Iron | 5.21 | 16604332 | 
| MESH:D002318 | Cardiovascular Diseases |  | Arsenic | 9.55 | 15738583	19152805	17938729 | 
| MESH:D002318 | Cardiovascular Diseases |  | resveratrol | 9.55 | 15458977 | 
| MESH:D002318 | Cardiovascular Diseases |  | valsartan | 9.55 | 11230374 | 
| MESH:D002340 | Carotid Artery Diseases | marker/mechanism |  |  | 18022660 | 
| MESH:D002340 | Carotid Artery Diseases |  | Arsenic | 3.73 | 16973168	18022660 | 
| MESH:D002341 | Carotid Artery Thrombosis |  | Amiodarone | 4.41 | 18974383 | 
| MESH:D016893 | Carotid Stenosis | marker/mechanism |  |  | 17243563 | 
| MESH:D002386 | Cataract |  | Acetaminophen | 5.78 | 10977129 | 
| MESH:D002386 | Cataract |  | Tretinoin | 5.78 | 17460283 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | Cyclosporine | 12.07 | 12371664 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | Diethylnitrosamine | 12.07 | 7505956	17174075	2727394	21159647 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | sodium arsenite | 12.07 | 19524636	20056578 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | tobacco tar | 12.07 | 19559774 | 
| MESH:D002493 | Central Nervous System Diseases |  | Phenobarbital | 9.49 | 4080065 | 
| MESH:D002493 | Central Nervous System Diseases |  | Phenytoin | 9.49 | 4080065 | 
| MESH:D016657 | Cerebral Amyloid Angiopathy | marker/mechanism |  |  | 11061249 | 
| MESH:D002543 | Cerebral Hemorrhage |  | Warfarin | 5.20 | 11061249 | 
| MESH:D018290 | Cervical Intraepithelial Neoplasia |  | Tretinoin | 3.92 | 16129372 | 
| MESH:D018281 | Cholangiocarcinoma |  | Diethylnitrosamine | 7.41 | 19052882 | 
| MESH:D018281 | Cholangiocarcinoma |  | Tetrachlorodibenzodioxin | 7.41 | 16835633 | 
| MESH:D002779 | Cholestasis |  | Cyclosporine | 10.35 | 19486331 | 
| MESH:D002779 | Cholestasis |  | Ethinyl Estradiol | 10.35 | 17110522	11677210	15861022	17333356	16105132	17681005	16919318 | 
| MESH:D002779 | Cholestasis |  | pirinixic acid | 10.35 | 19176532 | 
| OMIM:601042 | CHOREOATHETOSIS/SPASTICITY, EPISODIC |  | Phenytoin | 5.20 | 11748493 | 
| MESH:D002822 | Choriocarcinoma |  | Tretinoin | 4.47 | 16461808 | 
| MESH:D002971 | Cleft Lip |  | Phenytoin | 3.76 | 2227380 | 
| MESH:D002972 | Cleft Palate |  | Phenytoin | 7.97 | 6856622	3877104	2227380	10789828	6862529	1687470 | 
| MESH:D002972 | Cleft Palate |  | Tetrachlorodibenzodioxin | 7.97 | 12621046	15340226	15668235	16354765	8697196 | 
| MESH:D002972 | Cleft Palate |  | Tretinoin | 7.97 | 9407595 | 
| MESH:D003092 | Colitis |  | resveratrol | 12.27 | 16474422 | 
| MESH:D003092 | Colitis |  | Selenium | 12.27 | 17936198 | 
| MESH:D003092 | Colitis |  | Tretinoin | 12.27 | 17035595 | 
| MESH:D003103 | Coloboma |  | Phenytoin | 4.54 | 9212184 | 
| MESH:D003110 | Colonic Neoplasms |  | Iron | 6.89 | 16640825 | 
| MESH:D003110 | Colonic Neoplasms |  | polyphenols | 6.89 | 16293270 | 
| MESH:D003110 | Colonic Neoplasms |  | Quercetin | 6.89 | 19440933	11134977	15741050	16640504	19056647	17191121	17148506 | 
| MESH:D003110 | Colonic Neoplasms |  | resveratrol | 6.89 | 16338953 | 
| MESH:D015179 | Colorectal Neoplasms |  | Acrolein | 3.17 | 17597105 | 
| MESH:D015179 | Colorectal Neoplasms |  | Quercetin | 3.17 | 18095365	18852136 | 
| MESH:D015179 | Colorectal Neoplasms |  | resveratrol | 3.17 | 16550006 | 
| MESH:D000013 | Congenital Abnormalities |  | Phenytoin | 7.48 | 10627286 | 
| MESH:D000013 | Congenital Abnormalities |  | Tetrachlorodibenzodioxin | 7.48 | 14669216	17141729 | 
| MESH:D003324 | Coronary Artery Disease |  | atorvastatin | 5.92 | 16368305 | 
| MESH:D003324 | Coronary Artery Disease |  | valsartan | 5.92 | 17719468 | 
| MESH:D003327 | Coronary Disease |  | Fructose | 7.23 | 18504504 | 
| MESH:D003327 | Coronary Disease |  | resveratrol | 7.23 | 16507316 | 
| MESH:D023903 | Coronary Restenosis |  | Warfarin | 5.04 | 12872399 | 
| MESH:D003371 | Cough |  | Enalapril | 5.54 | 11725383 | 
| OMIM:122700 | COUMARIN RESISTANCE |  | Warfarin | 5.20 | 20579077	20497562 | 
| MESH:D003384 | Coxsackievirus Infections |  | valsartan | 5.17 | 20392896 | 
| MESH:D006259 | Craniocerebral Trauma | marker/mechanism |  |  |  | 
| MESH:D019465 | Craniofacial Abnormalities |  | Phenytoin | 3.31 | 8986270	9212184	19952982 | 
| MESH:D019465 | Craniofacial Abnormalities |  | Tetrachlorodibenzodioxin | 3.31 | 15322242	10048152	20055451 | 
| MESH:D019465 | Craniofacial Abnormalities |  | Tretinoin | 3.31 | 9664655	10589399	14991402	17551590	9125849	16925845	8800419	9142499	9224671	9211117 | 
| MESH:D003456 | Cryptorchidism |  | Diethylstilbestrol | 3.92 | 16002989	12952375 | 
| MESH:D003556 | Cystitis |  | Acrolein | 9.81 | 12161096 | 
| MESH:D003556 | Cystitis |  | Cyclophosphamide | 9.81 | 10700343	12913760	17010015	17979934	18295254	18433785	16651033	15643279	18483878	18710439	12161096	12388444	10498854	16989017	18093676	16413132	18372110	16614059	11948286	15276878 | 
| MESH:D003711 | Demyelinating Diseases |  | Tamoxifen | 3.71 | 19031437 | 
| MESH:D003866 | Depressive Disorder |  | tolcapone | 3.81 | 11224284	7768276 | 
| MESH:D003865 | Depressive Disorder, Major |  | tolcapone | 4.33 | 10440460 | 
| MESH:D017449 | Dermatitis, Allergic Contact |  | nickel sulfate | 3.07 | 11298694	16780908	16823706 | 
| MESH:D003876 | Dermatitis, Atopic |  | pirinixic acid | 2.07 | 18249437 | 
| MESH:D003920 | Diabetes Mellitus |  | Iron | 7.92 | 16640825	16604332 | 
| MESH:D003920 | Diabetes Mellitus |  | Streptozocin | 7.92 | 16285004 | 
| MESH:D003921 | Diabetes Mellitus, Experimental |  | Cyclophosphamide | 30.33 | 11751995	10990075	15331540 | 
| MESH:D003921 | Diabetes Mellitus, Experimental |  | Fructose | 30.33 | 18603373 | 
| MESH:D003921 | Diabetes Mellitus, Experimental |  | Quercetin | 30.33 | 19496084 | 
| MESH:D003921 | Diabetes Mellitus, Experimental |  | resveratrol | 30.33 | 16873680 | 
| MESH:D003921 | Diabetes Mellitus, Experimental |  | Streptozocin | 30.33 | 12093613	15862027	12644472	17874149	17442507	12083368	6379147	12446591	15298345	19586609	19298542	19496084	11055810	18715473	8740154	16286809	7637645	18603373	19960420	11260395	1374869	2177838	16684804	15831366 | 
| MESH:D003921 | Diabetes Mellitus, Experimental |  | valsartan | 30.33 | 11508273 | 
| MESH:D003921 | Diabetes Mellitus, Experimental |  | vanadyl sulfate | 30.33 | 16684804 | 
| MESH:D003922 | Diabetes Mellitus, Type 1 |  | Cyclophosphamide | 10.66 | 18772604 | 
| MESH:D003922 | Diabetes Mellitus, Type 1 |  | Iron | 10.66 | 16506275 | 
| MESH:D003922 | Diabetes Mellitus, Type 1 |  | Streptozocin | 10.66 | 18603373 | 
| MESH:D003922 | Diabetes Mellitus, Type 1 |  | Warfarin | 10.66 | 18772604 | 
| MESH:D003924 | Diabetes Mellitus, Type 2 |  | Diethylnitrosamine | 11.27 | 20387270 | 
| MESH:D003924 | Diabetes Mellitus, Type 2 |  | Fructose | 11.27 | 18603373 | 
| MESH:D003924 | Diabetes Mellitus, Type 2 |  | Iron | 11.27 | 16506275 | 
| MESH:D003924 | Diabetes Mellitus, Type 2 |  | Streptozocin | 11.27 | 19586609	19647726 | 
| MESH:D003924 | Diabetes Mellitus, Type 2 |  | Tetrachlorodibenzodioxin | 11.27 | 17107852 | 
| MESH:D058065 | Diabetic Cardiomyopathies |  | Streptozocin | 5.05 | 16025228 | 
| MESH:D003928 | Diabetic Nephropathies |  | resveratrol | 22.08 | 16286809 | 
| MESH:D003928 | Diabetic Nephropathies |  | Streptozocin | 22.08 | 19682444	19960420 | 
| MESH:D003928 | Diabetic Nephropathies |  | Tamoxifen | 22.08 | 19279558 | 
| MESH:D003928 | Diabetic Nephropathies |  | valsartan | 22.08 | 11427623	18630688 | 
| MESH:D003928 | Diabetic Nephropathies |  | Warfarin | 22.08 | 12644472 | 
| MESH:D003930 | Diabetic Retinopathy |  | Streptozocin | 4.78 | 17662242 | 
| OMIM:607208 | DRAVET SYNDROME |  | Phenytoin | 4.73 | 11748493 | 
| MESH:D003875 | Drug Eruptions |  | Phenytoin | 10.80 | 15024534 | 
| MESH:D003875 | Drug Eruptions |  | Warfarin | 10.80 | 14723717 | 
| MESH:D056486 | Drug-Induced Liver Injury | marker/mechanism |  |  | 16099942 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Acetaminophen | 17.63 | 17522070	14550746	16227642	17562736	11834606	10663392	14986274	19370779	15619225	19164858	11421492	12594235	15968718	11529661	12958197	16393943	19420014	12392966	10774834	19923254	19085960	2444490	16109766	12540782	14725611	12153990	12705907	16485898	19416960	11287661	16177239	11743745	18071297	18713872	16781746	16081117	19739265	17906064	11739529	11461765	10915739 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Amiodarone | 17.63 | 18218290	15265979 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Carbon Tetrachloride | 17.63 | 7120509	10092053	3732212	15027814	6884620	21278145	7179309	10915739	15998439	19336974	3786805	16177239	6623471	19085960	16227642	2869522	7440962	9327722	17522070	4309450	11566570	15968718 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Diethylnitrosamine | 17.63 | 19107877 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | polyphenols | 17.63 | 19370779 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Selenium | 17.63 | 15131321 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Tetrachlorodibenzodioxin | 17.63 | 20420201 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | tolcapone | 17.63 | 16604736	19783845 | 
| MESH:D056487 | Drug-Induced Liver Injury, Chronic |  | Acetaminophen | 3.41 | 19426721 | 
| MESH:D004362 | Drug Toxicity |  | Tetrachlorodibenzodioxin | 2.25 | 11462148 | 
| MESH:D004409 | Dyskinesia, Drug-Induced |  | tolcapone | 4.72 | 11455177 | 
| MESH:D050171 | Dyslipidemias |  | Dietary Fats | 2.95 | 18367378 | 
| MESH:D004417 | Dyspnea |  | cypermethrin | 4.71 | 16487989 | 
| MESH:D004421 | Dystonia |  | Phenobarbital | 3.38 | 1851702 | 
| MESH:D004487 | Edema |  | pirinixic acid | 8.00 | 12083418 | 
| MESH:D004487 | Edema |  | resveratrol | 8.00 | 8985016 | 
| MESH:D004487 | Edema |  | Tetrachlorodibenzodioxin | 8.00 | 12711302	11000095 | 
| MESH:D004489 | Edema, Cardiac |  | Tetrachlorodibenzodioxin | 9.67 | 16714409	18230668	15322242 | 
| MESH:D004489 | Edema, Cardiac |  | Tretinoin | 9.67 | 18230668 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Ethinyl Estradiol | 16.77 | 12538720 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Phenytoin | 16.77 | 17654737 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | resveratrol | 16.77 | 17872969 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Tamoxifen | 16.77 | 19031437 | 
| MESH:D004714 | Endometrial Hyperplasia |  | Diethylstilbestrol | 4.02 | 16402032 | 
| MESH:D016889 | Endometrial Neoplasms |  | Diethylstilbestrol | 9.76 | 15700306	16804899 | 
| MESH:D016889 | Endometrial Neoplasms |  | Tamoxifen | 9.76 | 20544844	19155303	17893378	16202921 | 
| MESH:D016889 | Endometrial Neoplasms |  | Tretinoin | 9.76 | 16569247 | 
| MESH:D004715 | Endometriosis |  | Tetrachlorodibenzodioxin | 2.44 | 9294722	10568697 | 
| MESH:D019446 | Endotoxemia |  | Lipopolysaccharides | 3.73 | 15328337	15821434	17637181 | 
| MESH:D020345 | Enterocolitis, Necrotizing |  | resveratrol | 4.19 | 17923197 | 
| MESH:D004802 | Eosinophilia |  | Cyclophosphamide | 3.57 | 11006010 | 
| MESH:D004816 | Epidermal Necrolysis, Toxic |  | Phenytoin | 4.56 | 20235791 | 
| MESH:D004820 | Epidermolysis Bullosa |  | Phenytoin | 5.55 | 6251365	1399206 | 
| MESH:D004831 | Epilepsies, Myoclonic |  | Phenobarbital | 3.45 | 3659116 | 
| MESH:D004828 | Epilepsies, Partial |  | Phenobarbital | 8.08 | 3922381	11558140 | 
| MESH:D004828 | Epilepsies, Partial |  | Phenytoin | 8.08 | 17116037	11558140 | 
| MESH:D004827 | Epilepsy |  | Phenobarbital | 5.73 | 20417680 | 
| MESH:D004827 | Epilepsy |  | Phenytoin | 5.73 | 11434505	20417680	821787 | 
| MESH:D004832 | Epilepsy, Absence |  | Phenobarbital | 2.97 | 6401628 | 
| MESH:D017029 | Epilepsy, Complex Partial |  | Phenobarbital | 9.49 | 7750514 | 
| MESH:D017029 | Epilepsy, Complex Partial |  | Phenytoin | 9.49 | 7750514 | 
| MESH:D004830 | Epilepsy, Tonic-Clonic |  | Phenobarbital | 8.63 | 3659116 | 
| MESH:D004830 | Epilepsy, Tonic-Clonic |  | Phenytoin | 8.63 | 3659116 | 
| MESH:D004931 | Esophageal Achalasia |  | Diethylnitrosamine | 4.43 | 16302075 | 
| MESH:D004938 | Esophageal Neoplasms |  | nitrosobenzylmethylamine | 2.58 | 15878914	15623463	16510608	16704527	15547733	15150132	15264214	15547721	16805852 | 
| MESH:D054908 | Extensively Drug-Resistant Tuberculosis |  | tolcapone | 5.26 | 19578428 | 
| MESH:D005124 | Eye Abnormalities |  | Tetrachlorodibenzodioxin | 7.10 | 11564622 | 
| MESH:D005124 | Eye Abnormalities |  | Tretinoin | 7.10 | 16938888	9664655 | 
| MESH:D005234 | Fatty Liver |  | Amiodarone | 43.27 | 14986274 | 
| MESH:D005234 | Fatty Liver |  | Carbon Tetrachloride | 43.27 | 61145	16239168	19224547	15959796	12795759	16045604	12631006	17595544 | 
| MESH:D005234 | Fatty Liver |  | Cyclosporine | 43.27 | 19224547 | 
| MESH:D005234 | Fatty Liver |  | Dietary Fats | 43.27 | 17967931	19004024	18296743	19551842 | 
| MESH:D005234 | Fatty Liver |  | Diethylnitrosamine | 43.27 | 21071580	20387270 | 
| MESH:D005234 | Fatty Liver |  | Ethinyl Estradiol | 43.27 | 15345470 | 
| MESH:D005234 | Fatty Liver |  | Fructose | 43.27 | 18395287	18641190	19196556 | 
| MESH:D005234 | Fatty Liver |  | Iron | 43.27 | 16640825 | 
| MESH:D005234 | Fatty Liver |  | pirinixic acid | 43.27 | 19236843	20131406 | 
| MESH:D005234 | Fatty Liver |  | Tamoxifen | 43.27 | 19224547	14986274 | 
| MESH:D052776 | Female Urogenital Diseases |  | Diethylstilbestrol | 6.73 | 16534752	16513791	16611131	16002989	15751030 | 
| MESH:D052776 | Female Urogenital Diseases |  | Tamoxifen | 6.73 | 16709447 | 
| MESH:D005313 | Fetal Death |  | Phenytoin | 8.56 | 10627286 | 
| MESH:D005313 | Fetal Death |  | Tetrachlorodibenzodioxin | 8.56 | 11858732 | 
| MESH:D005334 | Fever |  | Lipopolysaccharides | 3.43 | 11852909	9205823 | 
| MESH:D018221 | Fibromatosis, Abdominal |  | Tamoxifen | 3.86 | 14745880 | 
| MESH:D018222 | Fibromatosis, Aggressive |  | Tamoxifen | 3.51 | 19069698 | 
| MESH:D005355 | Fibrosis |  | Carbon Tetrachloride | 37.16 | 18705752 | 
| MESH:D005355 | Fibrosis |  | Cyclosporine | 37.16 | 12168785	12639820 | 
| MESH:D005355 | Fibrosis |  | Dietary Fats | 37.16 | 18296743 | 
| MESH:D005355 | Fibrosis |  | Fructose | 37.16 | 18504504 | 
| MESH:D005355 | Fibrosis |  | Quercetin | 37.16 | 19474275 | 
| MESH:D005355 | Fibrosis |  | Tetrachlorodibenzodioxin | 37.16 | 20067830 | 
| MESH:D005355 | Fibrosis |  | Tretinoin | 37.16 | 17994277 | 
| MESH:D005355 | Fibrosis |  | valsartan | 37.16 | 16893502 | 
| MESH:D005534 | Foot Diseases |  | Arsenic | 4.87 | 6392382 | 
| MESH:D005621 | Friedreich Ataxia |  | Iron | 4.77 | 16640825	16604332 | 
| MESH:D005756 | Gastritis |  | Acetaminophen | 2.99 | 16983495 | 
| MESH:D006471 | Gastrointestinal Hemorrhage |  | Warfarin | 6.03 | 11794436 | 
| MESH:D005776 | Gaucher Disease |  | Warfarin | 5.32 | 12359135 | 
| MESH:D005833 | Genital Neoplasms, Female |  | Diethylstilbestrol | 10.58 | 16452187 | 
| MESH:D005833 | Genital Neoplasms, Female |  | sodium arsenite | 10.58 | 16452187 | 
| MESH:D005885 | Gingival Hyperplasia |  | Cyclosporine | 10.68 | 8708960 | 
| MESH:D005885 | Gingival Hyperplasia |  | Phenytoin | 10.68 | 9029455 | 
| MESH:D019214 | Gingival Overgrowth |  | Phenytoin | 5.55 | 16390469	14659971 | 
| MESH:D005909 | Glioblastoma |  | Quercetin | 5.70 | 19804834 | 
| MESH:D005909 | Glioblastoma |  | Tretinoin | 5.70 | 17312396 | 
| MESH:D005910 | Glioma |  | Quercetin | 2.75 | 17643826 | 
| MESH:D018316 | Gliosarcoma |  | Cyclophosphamide | 4.84 | 11389073 | 
| MESH:D015432 | Glomerulonephritis, Membranoproliferative |  | valsartan | 4.90 | 16928621 | 
| MESH:D018149 | Glucose Intolerance |  | Fructose | 4.70 | 19165636 | 
| MESH:D006058 | Gonadal Disorders |  | Tetrachlorodibenzodioxin | 3.91 | 10696789 | 
| MESH:D006086 | Graft vs Host Disease |  | Cyclophosphamide | 4.38 | 15172196	11014644	16376943 | 
| MESH:D006258 | Head and Neck Neoplasms |  | Tretinoin | 2.71 | 16096774 | 
| MESH:D006317 | Hearing Loss, Noise-Induced |  | Tretinoin | 4.47 | 16084493 | 
| MESH:D006330 | Heart Defects, Congenital |  | Tetrachlorodibenzodioxin | 5.21 | 10048152	11294989 | 
| MESH:D006330 | Heart Defects, Congenital |  | Tretinoin | 5.21 | 9664655	14991402 | 
| MESH:D006331 | Heart Diseases |  | Streptozocin | 3.79 | 12093613 | 
| MESH:D006333 | Heart Failure |  | atorvastatin | 17.49 | 16360360 | 
| MESH:D006333 | Heart Failure |  | Enalapril | 17.49 | 10979640	12514674 | 
| MESH:D006333 | Heart Failure |  | pirinixic acid | 17.49 | 20558911 | 
| MESH:D006333 | Heart Failure |  | Selenium | 17.49 | 17162251 | 
| MESH:D006333 | Heart Failure |  | valsartan | 17.49 | 19027736 | 
| MESH:D006406 | Hematoma |  | Warfarin | 6.03 | 17493413 | 
| MESH:D006432 | Hemochromatosis |  | Iron | 3.98 | 17053826	16640825	16604332	16574947	17255318	17236123 | 
| MESH:D006457 | Hemoglobinuria, Paroxysmal |  | Cyclosporine | 3.75 | 15720958 | 
| MESH:D006463 | Hemolytic-Uremic Syndrome |  | Lipopolysaccharides | 3.79 | 16366002 | 
| MESH:D006467 | Hemophilia A |  | Cyclophosphamide | 4.63 | 11918545 | 
| MESH:D006470 | Hemorrhage |  | Tetrachlorodibenzodioxin | 8.49 | 11000095 | 
| MESH:D006470 | Hemorrhage |  | Warfarin | 8.49 | 18429757 | 
| MESH:D006486 | Hemosiderosis |  | Iron | 4.53 | 16604332 | 
| MESH:D006504 | Hepatic Veno-Occlusive Disease |  | Cyclophosphamide | 4.85 | 14986274 | 
| MESH:D006505 | Hepatitis |  | Carbon Tetrachloride | 7.72 | 19900420	19110552 | 
| MESH:D006505 | Hepatitis |  | cypermethrin | 7.72 | 16487989 | 
| MESH:D006525 | Hepatitis, Viral, Human |  | Iron | 4.78 | 16640825 | 
| MESH:D006527 | Hepatolenticular Degeneration |  | Iron | 4.28 | 17182432 | 
| MESH:D006529 | Hepatomegaly |  | Amiodarone | 20.26 | 15265979 | 
| MESH:D006529 | Hepatomegaly |  | Iron | 20.26 | 16890145 | 
| MESH:D006529 | Hepatomegaly |  | Phenobarbital | 20.26 | 16109766 | 
| MESH:D006529 | Hepatomegaly |  | pirinixic acid | 20.26 | 18467677	16221962	19176532	19772884 | 
| MESH:D006529 | Hepatomegaly |  | Tetrachlorodibenzodioxin | 20.26 | 15340226	16120746	12621046 | 
| MESH:D006561 | Herpes Simplex |  | resveratrol | 3.52 | 16876885 | 
| MESH:D015658 | HIV Infections |  | Iron | 3.29 | 16597321 | 
| MESH:D006689 | Hodgkin Disease |  | Cyclophosphamide | 5.74 | 16135485	17606976 | 
| MESH:D006689 | Hodgkin Disease |  | sodium arsenite | 5.74 | 12676792 | 
| MESH:D006869 | Hydronephrosis |  | Tetrachlorodibenzodioxin | 3.36 | 18606429	8697196	16959395	15340226	16354765 | 
| MESH:D006930 | Hyperalgesia |  | Acetaminophen | 5.83 | 16870215 | 
| MESH:D006930 | Hyperalgesia |  | Tretinoin | 5.83 | 16870215 | 
| MESH:D006932 | Hyperbilirubinemia |  | Carbon Tetrachloride | 3.86 | 16899240 | 
| MESH:D006937 | Hypercholesterolemia |  | Amiodarone | 27.73 | 8137927	9751232 | 
| MESH:D006937 | Hypercholesterolemia |  | atorvastatin | 27.73 | 11583720 | 
| MESH:D006937 | Hypercholesterolemia |  | Cholesterol | 27.73 | 16933029 | 
| MESH:D006937 | Hypercholesterolemia |  | Cholesterol, Dietary | 27.73 | 10876104 | 
| MESH:D006937 | Hypercholesterolemia |  | Dietary Fats | 27.73 | 21332399 | 
| MESH:D006937 | Hypercholesterolemia |  | resveratrol | 27.73 | 17188708 | 
| MESH:D017681 | Hypereosinophilic Syndrome |  | Tretinoin | 3.91 | 16778211 | 
| MESH:D006943 | Hyperglycemia |  | pirinixic acid | 7.28 | 20558911 | 
| MESH:D006943 | Hyperglycemia |  | Quercetin | 7.28 | 11834736	18262572 | 
| MESH:D020138 | Hyperhomocysteinemia |  | Phenytoin | 4.10 | 10459572 | 
| MESH:D006946 | Hyperinsulinism |  | Fructose | 4.33 | 14757778	18563319	19008412	18360027	15752949 | 
| MESH:D017488 | Hyperkeratosis, Epidermolytic |  | Arsenic | 3.86 | 17050553 | 
| MESH:D006949 | Hyperlipidemias |  | Dietary Fats | 12.01 | 21332399 | 
| MESH:D006949 | Hyperlipidemias |  | Fructose | 12.01 | 15752949 | 
| MESH:D006949 | Hyperlipidemias |  | resveratrol | 12.01 | 16873680 | 
| MESH:D006951 | Hyperlipoproteinemias | marker/mechanism |  |  |  | 
| MESH:D006938 | Hyperlipoproteinemia Type II | marker/mechanism |  |  | 16030523 | 
| MESH:D006938 | Hyperlipoproteinemia Type II |  | atorvastatin | 4.62 | 16238680 | 
| MESH:D006952 | Hyperlipoproteinemia Type III | marker/mechanism |  |  |  | 
| MESH:D006965 | Hyperplasia |  | Diethylstilbestrol | 3.78 | 12960047	14722030 | 
| MESH:D006973 | Hypertension |  | Arsenic | 27.96 | 16076760	11953799	9931084 | 
| MESH:D006973 | Hypertension |  | atorvastatin | 27.96 | 17042910 | 
| MESH:D006973 | Hypertension |  | Cyclosporine | 27.96 | 10903974 | 
| MESH:D006973 | Hypertension |  | Enalapril | 27.96 | 12717102	10903974 | 
| MESH:D006973 | Hypertension |  | Fructose | 27.96 | 14568997	16843071	14633139	19008412	14573337 | 
| MESH:D006973 | Hypertension |  | Phenylephrine | 27.96 | 8949925	12717712 | 
| MESH:D006973 | Hypertension |  | Quercetin | 27.96 | 18356687 | 
| MESH:D006973 | Hypertension |  | Tetrachlorodibenzodioxin | 27.96 | 18670907	18850075 | 
| MESH:D006973 | Hypertension |  | valsartan | 27.96 | 12692753	20102058	18390891	18344623	10903974	16475468	11427623	12850387 | 
| MESH:D006974 | Hypertension, Malignant |  | valsartan | 5.72 | 11560862 | 
| MESH:D006975 | Hypertension, Portal |  | Carbon Tetrachloride | 3.43 | 15338365 | 
| MESH:D006976 | Hypertension, Pulmonary |  | Warfarin | 4.31 | 12359135 | 
| MESH:D015228 | Hypertriglyceridemia | marker/mechanism |  |  |  | 
| MESH:D015228 | Hypertriglyceridemia |  | Fructose | 4.49 | 19342510	19799862 | 
| MESH:D006984 | Hypertrophy |  | Phenylephrine | 3.95 | 18502941	12791704 | 
| MESH:D017379 | Hypertrophy, Left Ventricular |  | resveratrol | 3.71 | 17488730 | 
| MESH:D006987 | Hypesthesia |  | Arsenic | 4.87 | 16093927 | 
| MESH:D007006 | Hypogonadism |  | Iron | 3.90 | 16640825 | 
| MESH:D007021 | Hypospadias |  | Diethylstilbestrol | 9.07 | 16002989 | 
| MESH:D007021 | Hypospadias |  | Ethinyl Estradiol | 9.07 | 16945680	16569931 | 
| MESH:D007037 | Hypothyroidism |  | Amiodarone | 9.51 | 18020914	17991464 | 
| MESH:D007037 | Hypothyroidism |  | Iron | 9.51 | 16640825 | 
| MESH:D007154 | Immune System Diseases |  | Cyclophosphamide | 4.65 | 16076520 | 
| MESH:D020244 | Infarction, Middle Cerebral Artery |  | resveratrol | 3.99 | 17600658 | 
| MESH:D007246 | Infertility |  | Diethylstilbestrol | 3.72 | 15036965 | 
| MESH:D007247 | Infertility, Female |  | Ethinyl Estradiol | 2.84 | 12013081 | 
| MESH:D007248 | Infertility, Male |  | Cyclophosphamide | 8.52 | 16517039	7193160 | 
| MESH:D007248 | Infertility, Male |  | Ethinyl Estradiol | 8.52 | 17937319 | 
| MESH:D007248 | Infertility, Male |  | sodium arsenite | 8.52 | 12646999	15346721 | 
| MESH:D007249 | Inflammation |  | atorvastatin | 21.68 | 16908763 | 
| MESH:D007249 | Inflammation |  | Dietary Fats | 21.68 | 20412841 | 
| MESH:D007249 | Inflammation |  | Diethylnitrosamine | 21.68 | 18785209 | 
| MESH:D007249 | Inflammation |  | Lipopolysaccharides | 21.68 | 17963957	9205823	17255318	17237260	12878042 | 
| MESH:D007249 | Inflammation |  | polyphenols | 21.68 | 16366677 | 
| MESH:D007249 | Inflammation |  | resveratrol | 21.68 | 16366677 | 
| MESH:D007249 | Inflammation |  | Tamoxifen | 21.68 | 19457130 | 
| MESH:D007249 | Inflammation |  | Tetrachlorodibenzodioxin | 21.68 | 12200463	12878042 | 
| MESH:D007251 | Influenza, Human |  | Quercetin | 14.72 | 16624496 | 
| MESH:D007251 | Influenza, Human |  | resveratrol | 14.72 | 16624496 | 
| MESH:D007251 | Influenza, Human |  | Selenium | 14.72 | 16624496 | 
| MESH:D007299 | Insect Bites and Stings |  | cypermethrin | 5.29 | 15189238 | 
| MESH:D007333 | Insulin Resistance |  | Dietary Fats | 9.74 | 18457598	11836018 | 
| MESH:D007333 | Insulin Resistance |  | Fructose | 9.74 | 14633139	19799862	18563319	17133782	19008412	14757778	19586609	18981581	19342510	14573337	18057795 | 
| MESH:D007333 | Insulin Resistance |  | pirinixic acid | 9.74 | 16306350 | 
| MESH:D007410 | Intestinal Diseases |  | Tretinoin | 3.12 | 17994277 | 
| MESH:D019189 | Iron Metabolism Disorders |  | Iron | 9.52 | 17163184 | 
| MESH:D019189 | Iron Metabolism Disorders |  | Lipopolysaccharides | 9.52 | 17255318 | 
| MESH:D007569 | Jaw Abnormalities |  | Tetrachlorodibenzodioxin | 7.92 | 16580747 | 
| MESH:D007569 | Jaw Abnormalities |  | Tretinoin | 7.92 | 15992940	17551590 | 
| MESH:D007627 | Keloid |  | Quercetin | 4.30 | 17086741 | 
| MESH:D007638 | Keratoconjunctivitis Sicca |  | Cyclosporine | 3.76 | 15604871 | 
| MESH:D007642 | Keratosis |  | Arsenic | 4.32 | 16930632	12749816 | 
| MESH:D007674 | Kidney Diseases |  | Acetaminophen | 26.46 | 12587719	15629191 | 
| MESH:D007674 | Kidney Diseases |  | Acrolein | 26.46 | 12488133 | 
| MESH:D007674 | Kidney Diseases |  | Cyclosporine | 26.46 | 8314463	10903974	18776723 | 
| MESH:D007674 | Kidney Diseases |  | Enalapril | 26.46 | 10903974 | 
| MESH:D007674 | Kidney Diseases |  | Quercetin | 26.46 | 16962696 | 
| MESH:D007674 | Kidney Diseases |  | sodium arsenite | 26.46 | 20008137 | 
| MESH:D007674 | Kidney Diseases |  | Streptozocin | 26.46 | 12093613 | 
| MESH:D007674 | Kidney Diseases |  | valsartan | 26.46 | 16893502	10903974	12164870 | 
| MESH:D007676 | Kidney Failure, Chronic |  | Selenium | 3.28 | 16518626 | 
| MESH:D007680 | Kidney Neoplasms |  | Cyclosporine | 9.24 | 12371664 | 
| MESH:D007680 | Kidney Neoplasms |  | Diethylstilbestrol | 9.24 | 16762066	14681315	15003126 | 
| MESH:D007680 | Kidney Neoplasms |  | Tamoxifen | 9.24 | 18625569 | 
| MESH:D007683 | Kidney Tubular Necrosis, Acute |  | Calcium | 4.36 | 16316344 | 
| MESH:D007859 | Learning Disorders |  | Cholesterol | 7.95 | 17134702 | 
| MESH:D007859 | Learning Disorders |  | Diethylstilbestrol | 7.95 | 17184923 | 
| MESH:D007938 | Leukemia |  | Cyclophosphamide | 8.38 | 10602166 | 
| MESH:D007938 | Leukemia |  | Quercetin | 8.38 | 17468513 | 
| MESH:D007938 | Leukemia |  | Tretinoin | 8.38 | 17143497 | 
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell |  | Cyclophosphamide | 3.17 | 17802794	17658394	18172266	17008537	18587576	17296974 | 
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |  | Cyclophosphamide | 3.57 | 10373061 | 
| MESH:D007951 | Leukemia, Myeloid |  | Tretinoin | 3.10 | 19285840	16932348	16482212 | 
| MESH:D015470 | Leukemia, Myeloid, Acute |  | Tretinoin | 1.94 | 17596541	19850784	16294345 | 
| MESH:D015473 | Leukemia, Promyelocytic, Acute |  | Arsenic | 10.10 | 17339181 | 
| MESH:D015473 | Leukemia, Promyelocytic, Acute |  | resveratrol | 10.10 | 16087638 | 
| MESH:D015473 | Leukemia, Promyelocytic, Acute |  | Tretinoin | 10.10 | 17712046	16766008	9834237	15748426	16140955	17368321	19035177	12679006	19225113	17506722	17301526	17217047	17361223	16331271	16823087	16891316	17294898	19075265	16935935	19029980	19642359	16788101	17107899	17649720	17339181 | 
| MESH:D007970 | Leukopenia |  | Cyclophosphamide | 9.54 | 11830472	10052129 | 
| MESH:D007970 | Leukopenia |  | Lipopolysaccharides | 9.54 | 15821434 | 
| MESH:D020961 | Lewy Body Disease |  | Iron | 4.77 | 16563566 | 
| MESH:D017880 | Limb Deformities, Congenital |  | Tretinoin | 2.81 | 9224671 | 
| MESH:D008064 | Lipidoses |  | Amiodarone | 6.24 | 15342952	17567588 | 
| MESH:D008064 | Lipidoses |  | Tamoxifen | 6.24 | 15342952	17567588 | 
| OMIM:611771 | LIPOPROTEIN GLOMERULOPATHY | marker/mechanism |  |  |  | 
| MESH:D054068 | Livedo Reticularis |  | Warfarin | 6.03 | 18280355 | 
| MESH:D008103 | Liver Cirrhosis |  | Carbon Tetrachloride | 16.36 | 21278145	11903743	17334410	16239168	11408273	16221502	17174718	16943688	17157831 | 
| MESH:D008103 | Liver Cirrhosis |  | Dietary Fats | 16.36 | 18296743 | 
| MESH:D008103 | Liver Cirrhosis |  | Diethylnitrosamine | 16.36 | 18665156	20032147	18522880	19638242	18407596 | 
| MESH:D008103 | Liver Cirrhosis |  | Iron | 16.36 | 16640825 | 
| MESH:D008103 | Liver Cirrhosis |  | Phenobarbital | 16.36 | 21047994 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | alpha-naphthyl isocyanate | 17.80 | 16015684 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | atorvastatin | 17.80 | 17347453 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Carbon Tetrachloride | 17.80 | 15996030	12389079	18279442	15818738	12586293	14620537	18156304	17761835	16248980	18006644	12741479	15925388	17944888	14716496	17557913	17708605	17565644	18472332	12445421	16015684	16192424	14512876	18339082	15370692	17721639	12666154	18166357	17823541	15123356	18277467	12667390	18251166	10355542	18376398	15057751	17714472	15362042	14748882	15730626	17698563	16027843	16638106	15893842	18420326	15673190	18472094	18395914	17900296	17525996	12649538	12546737	14724832	18481824	12445418	13678700	14716833	18412020	20821823	16116963	17922224	12632514	16097048	18205269	18263696	15338365	11481614	12958196	15931870	17640975	17869086	17766677	18395095	17631135	17481882	12632512	17976157	12898905	15959796	18418968	18054572	15650968	12609069	18317297	16033810	18210741	16011737	17805973	15052691	15876570	16136751	18429990	18187930	18705752 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Enalapril | 17.80 | 17347453 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Lipopolysaccharides | 17.80 | 12878042 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | pirinixic acid | 17.80 | 15474484 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Quercetin | 17.80 | 12741479 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Tamoxifen | 17.80 | 18564211 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Tetrachlorodibenzodioxin | 17.80 | 12878042 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Tretinoin | 17.80 | 18397230	16248980 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | valsartan | 17.80 | 15504291	16872305	15619341 | 
| MESH:D008107 | Liver Diseases |  | Acetaminophen | 18.91 | 12969438	11587558	16611625	19460945	19014921	16610002	19784758	12587719 | 
| MESH:D008107 | Liver Diseases |  | Arsenic | 18.91 | 11134558 | 
| MESH:D008107 | Liver Diseases |  | Carbon Tetrachloride | 18.91 | 16246199	16964402	15830285	17285989	15720792 | 
| MESH:D008107 | Liver Diseases |  | cypermethrin | 18.91 | 15991261 | 
| MESH:D008107 | Liver Diseases |  | Diethylnitrosamine | 18.91 | 17034775 | 
| MESH:D008107 | Liver Diseases |  | Phenobarbital | 18.91 | 19363144 | 
| MESH:D008107 | Liver Diseases |  | Phenytoin | 18.91 | 14986274 | 
| MESH:D008107 | Liver Diseases |  | polyphenols | 18.91 | 16698588 | 
| MESH:D008108 | Liver Diseases, Alcoholic |  | Iron | 4.35 | 16737972	17207112 | 
| MESH:D017093 | Liver Failure |  | Carbon Tetrachloride | 3.51 | 15123358 | 
| MESH:D017114 | Liver Failure, Acute |  | Acetaminophen | 7.45 | 17185352	16871587 | 
| MESH:D017114 | Liver Failure, Acute |  | Carbon Tetrachloride | 7.45 | 16899240	14706259 | 
| MESH:D008113 | Liver Neoplasms |  | Aflatoxin B1 | 38.95 | 2125692	15890375	18177683	9163691 | 
| MESH:D008113 | Liver Neoplasms |  | Arsenic | 38.95 | 16368122 | 
| MESH:D008113 | Liver Neoplasms |  | Carbon Tetrachloride | 38.95 | 19294768 | 
| MESH:D008113 | Liver Neoplasms |  | Diethylnitrosamine | 38.95 | 20583210	18648771	18978307	19690152	19090486	20101389	19551842	19254457	19642983	19426721	19850985	15175105	21071580	19812893	15885732	18644402	19996281	19294768	20118626	18977376	21167192	18754104	20405173	20452335	21047994	9163691	20501860	16942905	20434301	21278145	20492335	20137499	19255062	19499222	2862719	12112319	2422723	19256749	10737359	12771043	19638242	19427195	19833225	19073162 | 
| MESH:D008113 | Liver Neoplasms |  | Diethylstilbestrol | 38.95 | 15890375	16712894 | 
| MESH:D008113 | Liver Neoplasms |  | Iron | 38.95 | 16640825	20302851 | 
| MESH:D008113 | Liver Neoplasms |  | Phenobarbital | 38.95 | 19073162	8742319	19812893	15975961	21047994	19482888 | 
| MESH:D008113 | Liver Neoplasms |  | pirinixic acid | 38.95 | 16377806	20007298	15890375 | 
| MESH:D008113 | Liver Neoplasms |  | Quercetin | 38.95 | 18980244 | 
| MESH:D008113 | Liver Neoplasms |  | resveratrol | 38.95 | 19321006	19073162	20405173	19812893 | 
| MESH:D008113 | Liver Neoplasms |  | sodium arsenite | 38.95 | 16712894	15276417 | 
| MESH:D008113 | Liver Neoplasms |  | Tamoxifen | 38.95 | 16684651 | 
| MESH:D008113 | Liver Neoplasms |  | Tetrachlorodibenzodioxin | 38.95 | 16984957 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Aflatoxin B1 | 17.51 | 8603461 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Carbon Tetrachloride | 17.51 | 15583823	12014681 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Diethylnitrosamine | 17.51 | 17854601	19126423	19009564	18253720	9362446	18775883	16267830	18093689	17174075	18164116	17942915	18079962	19004024	18544905	3124819	16842330	19519916	18308698	2563599	18282651	21159647	19539802 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Phenobarbital | 17.51 | 18308698	1399818	2563599	6150874	17172636 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Quercetin | 17.51 | 19519916 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Tetrachlorodibenzodioxin | 17.51 | 12151625 | 
| MESH:D008133 | Long QT Syndrome |  | Amiodarone | 3.06 | 17391786	15350150	11989578 | 
| MESH:D008171 | Lung Diseases |  | Acrolein | 13.71 | 11504702 | 
| MESH:D008171 | Lung Diseases |  | Amiodarone | 13.71 | 12587719 | 
| MESH:D008171 | Lung Diseases |  | Ozone | 13.71 | 19066396	8266340 | 
| MESH:D008171 | Lung Diseases |  | sodium arsenite | 13.71 | 19095001 | 
| MESH:D017563 | Lung Diseases, Interstitial |  | Amiodarone | 3.80 | 18516814 | 
| MESH:D055370 | Lung Injury |  | Lipopolysaccharides | 7.08 | 21114838 | 
| MESH:D055370 | Lung Injury |  | Ozone | 7.08 | 20417186 | 
| MESH:D008175 | Lung Neoplasms | marker/mechanism |  |  | 19180532 | 
| MESH:D008175 | Lung Neoplasms |  | Aflatoxin B1 | 12.90 | 14755239 | 
| MESH:D008175 | Lung Neoplasms |  | Arsenic | 12.90 | 17306315	19168569	17976673 | 
| MESH:D008175 | Lung Neoplasms |  | Diethylnitrosamine | 12.90 | 21163286	6695378	20970405	20512841 | 
| MESH:D008175 | Lung Neoplasms |  | Iron | 12.90 | 16640825 | 
| MESH:D008175 | Lung Neoplasms |  | Ozone | 12.90 | 8597069	7614698 | 
| MESH:D008175 | Lung Neoplasms |  | Quercetin | 12.90 | 16280456 | 
| MESH:D008175 | Lung Neoplasms |  | sodium arsenite | 12.90 | 16712894	15276417	17077188	19931552	17306315 | 
| MESH:D008175 | Lung Neoplasms |  | Tamoxifen | 12.90 | 18625569 | 
| MESH:D008175 | Lung Neoplasms |  | Tetrachlorodibenzodioxin | 12.90 | 19555203	11884234 | 
| MESH:D008181 | Lupus Nephritis |  | Diethylstilbestrol | 4.48 | 15166399 | 
| MESH:D008223 | Lymphoma |  | Cyclophosphamide | 6.22 | 12854902 | 
| MESH:D008223 | Lymphoma |  | Diethylstilbestrol | 6.22 | 15700306 | 
| MESH:D016393 | Lymphoma, B-Cell |  | Cyclophosphamide | 8.41 | 16675587 | 
| MESH:D016393 | Lymphoma, B-Cell |  | resveratrol | 8.41 | 17088997 | 
| MESH:D008228 | Lymphoma, Non-Hodgkin |  | Cyclophosphamide | 7.16 | 11911406 | 
| MESH:D008228 | Lymphoma, Non-Hodgkin |  | resveratrol | 7.16 | 14749477 | 
| MESH:D008268 | Macular Degeneration | marker/mechanism |  |  |  | 
| MESH:D008268 | Macular Degeneration |  | Iron | 3.57 | 16640825 | 
| MESH:D052801 | Male Urogenital Diseases |  | Diethylstilbestrol | 4.83 | 16002989 | 
| MESH:D015674 | Mammary Neoplasms, Animal |  | resveratrol | 7.78 | 15688416 | 
| MESH:D015674 | Mammary Neoplasms, Animal |  | Tamoxifen | 7.78 | 19428831 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | resveratrol | 7.36 | 8985016	11606380 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | Selenium | 7.36 | 15318939 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | Tamoxifen | 7.36 | 19196723	14580682	16827153	11731420	19196722 | 
| MESH:D020149 | Manganese Poisoning |  | Tamoxifen | 3.86 | 19453300 | 
| MESH:D008527 | Medulloblastoma |  | Tretinoin | 2.47 | 17453147 | 
| MESH:D008545 | Melanoma |  | resveratrol | 5.90 | 17992120 | 
| MESH:D008545 | Melanoma |  | sodium arsenite | 5.90 | 19082730	16487513 | 
| MESH:D008545 | Melanoma |  | Tamoxifen | 5.90 | 12393984	19393235 | 
| MESH:D008545 | Melanoma |  | Tretinoin | 5.90 | 16752155 | 
| MESH:D018328 | Melanoma, Amelanotic |  | Tamoxifen | 3.51 | 15990972 | 
| MESH:D008546 | Melanoma, Experimental |  | Acetaminophen | 14.70 | 19513568 | 
| MESH:D008546 | Melanoma, Experimental |  | Acrolein | 14.70 | 10803710 | 
| MESH:D008546 | Melanoma, Experimental |  | Cyclophosphamide | 14.70 | 16388313 | 
| MESH:D008591 | Meningomyelocele |  | Tretinoin | 3.77 | 16940565 | 
| MESH:D008607 | Mental Retardation |  | Phenytoin | 3.40 | 9212184 | 
| MESH:D008654 | Mesothelioma |  | Selenium | 2.48 | 15107826 | 
| MESH:D008659 | Metabolic Diseases |  | resveratrol | 3.77 | 17112576 | 
| MESH:D024821 | Metabolic Syndrome X |  | Fructose | 4.26 | 16815490	19165636	17098227	18497449	17261469 | 
| MESH:D008664 | Metal Metabolism, Inborn Errors |  | Cyclosporine | 4.10 | 16801185 | 
| MESH:D008679 | Metaplasia |  | Ozone | 4.42 | 10496685 | 
| MESH:D009101 | Multiple Myeloma |  | resveratrol | 2.98 | 16267019	14749477	16490592	17935668	17049120	17164350 | 
| MESH:D009103 | Multiple Sclerosis | marker/mechanism |  |  |  | 
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive |  | Iron | 4.99 | 17086897 | 
| MESH:D009134 | Muscular Atrophy, Spinal |  | resveratrol | 4.20 | 17962980 | 
| MESH:D009135 | Muscular Diseases |  | atorvastatin | 14.15 | 16239165 | 
| MESH:D009135 | Muscular Diseases |  | Bezafibrate | 14.15 | 16239165 | 
| MESH:D009135 | Muscular Diseases |  | pirinixic acid | 14.15 | 16239165 | 
| MESH:D009181 | Mycoses |  | Amiodarone | 10.87 | 17974566	12754197 | 
| MESH:D009181 | Mycoses |  | Iron | 10.87 | 16640825 | 
| MESH:D015878 | Mydriasis |  | Tropicamide | 6.67 | 16308726 | 
| MESH:D009190 | Myelodysplastic Syndromes |  | Tretinoin | 2.66 | 17596541 | 
| MESH:D009203 | Myocardial Infarction | marker/mechanism |  |  |  | 
| MESH:D009203 | Myocardial Infarction |  | pirinixic acid | 7.57 | 19151258 | 
| MESH:D009203 | Myocardial Infarction |  | Quercetin | 7.57 | 19595682 | 
| MESH:D009203 | Myocardial Infarction |  | resveratrol | 7.57 | 17125593	16525036	16317513	17188708	17015251	16456233 | 
| MESH:D017202 | Myocardial Ischemia |  | Arsenic | 17.39 | 15371236 | 
| MESH:D017202 | Myocardial Ischemia |  | Iron | 17.39 | 16604332 | 
| MESH:D017202 | Myocardial Ischemia |  | resveratrol | 17.39 | 17125593	17015251 | 
| MESH:D017202 | Myocardial Ischemia |  | Tetrachlorodibenzodioxin | 17.39 | 12213967 | 
| MESH:D015428 | Myocardial Reperfusion Injury |  | Iron | 11.25 | 16604332 | 
| MESH:D015428 | Myocardial Reperfusion Injury |  | pirinixic acid | 11.25 | 16411023 | 
| MESH:D015428 | Myocardial Reperfusion Injury |  | Quercetin | 11.25 | 19207477 | 
| MESH:D009205 | Myocarditis |  | resveratrol | 4.09 | 17322642 | 
| MESH:D020191 | Myoclonic Epilepsies, Progressive |  | Phenobarbital | 10.26 | 17484760 | 
| MESH:D020191 | Myoclonic Epilepsies, Progressive |  | Phenytoin | 10.26 | 17484760 | 
| MESH:D009224 | Myotonia Congenita |  | Phenytoin | 4.74 | 1896199 | 
| MESH:D009336 | Necrosis |  | Warfarin | 4.88 | 14723717 | 
| MESH:D009362 | Neoplasm Metastasis |  | Diethylnitrosamine | 4.66 | 9029167	3581430 | 
| MESH:D009362 | Neoplasm Metastasis |  | Tamoxifen | 4.66 | 19393235 | 
| MESH:D009364 | Neoplasm Recurrence, Local |  | Tamoxifen | 2.25 | 19410462 | 
| MESH:D009369 | Neoplasms |  | Acrolein | 18.20 | 17329238 | 
| MESH:D009369 | Neoplasms |  | Cyclophosphamide | 18.20 | 18854779 | 
| MESH:D009369 | Neoplasms |  | Diethylstilbestrol | 18.20 | 15313581 | 
| MESH:D009369 | Neoplasms |  | pirinixic acid | 18.20 | 17405874 | 
| MESH:D009369 | Neoplasms |  | Quercetin | 18.20 | 15185748 | 
| MESH:D009369 | Neoplasms |  | sodium arsenite | 18.20 | 11559025 | 
| MESH:D009369 | Neoplasms |  | Tretinoin | 18.20 | 16946489	16594593 | 
| MESH:D009374 | Neoplasms, Experimental |  | resveratrol | 7.07 | 8985016 | 
| MESH:D009374 | Neoplasms, Experimental |  | sodium arsenite | 7.07 | 20056578 | 
| MESH:D009376 | Neoplasms, Hormone-Dependent |  | Tamoxifen | 3.32 | 19196722	19200415	19189210 | 
| MESH:D009393 | Nephritis |  | Acrolein | 5.60 | 12653641 | 
| MESH:D009402 | Nephrosis, Lipoid |  | Cyclosporine | 3.76 | 17954296 | 
| MESH:D009404 | Nephrotic Syndrome |  | atorvastatin | 17.98 | 19348381 | 
| MESH:D009404 | Nephrotic Syndrome |  | Cyclosporine | 17.98 | 19348381	18481113 | 
| MESH:D009404 | Nephrotic Syndrome |  | Hypolipidemic Agents | 17.98 | 19603250 | 
| MESH:D009404 | Nephrotic Syndrome |  | Iron | 17.98 | 17178036 | 
| MESH:D009421 | Nervous System Malformations |  | Diethylstilbestrol | 12.71 | 11399458 | 
| MESH:D009421 | Nervous System Malformations |  | Tetrachlorodibenzodioxin | 12.71 | 14600291 | 
| MESH:D009421 | Nervous System Malformations |  | Tretinoin | 12.71 | 9125849 | 
| MESH:D009436 | Neural Tube Defects |  | Arsenic | 13.55 | 16620997 | 
| MESH:D009436 | Neural Tube Defects |  | Phenytoin | 13.55 | 9118846 | 
| MESH:D009436 | Neural Tube Defects |  | sodium arsenite | 13.55 | 12854658 | 
| MESH:D009436 | Neural Tube Defects |  | Tretinoin | 13.55 | 9142499 | 
| MESH:D009447 | Neuroblastoma |  | Cyclophosphamide | 3.25 | 8761367	15176712	16115947 | 
| MESH:D019636 | Neurodegenerative Diseases |  | Acetaminophen | 20.47 | 18514411 | 
| MESH:D019636 | Neurodegenerative Diseases |  | Acrolein | 20.47 | 11342003 | 
| MESH:D019636 | Neurodegenerative Diseases |  | Diethylnitrosamine | 20.47 | 20387270 | 
| MESH:D019636 | Neurodegenerative Diseases |  | Iron | 20.47 | 17296847	16604332 | 
| MESH:D019636 | Neurodegenerative Diseases |  | resveratrol | 20.47 | 17652729 | 
| MESH:D017599 | Neuroectodermal Tumors |  | Cyclophosphamide | 4.22 | 8761367	12837982 | 
| MESH:D020078 | Neurogenic Inflammation |  | Arsenic | 14.22 | 17056641 | 
| MESH:D020078 | Neurogenic Inflammation |  | Quercetin | 14.22 | 17929310 | 
| MESH:D020078 | Neurogenic Inflammation |  | resveratrol | 14.22 | 17929310 | 
| MESH:D009461 | Neurologic Manifestations |  | Diethylnitrosamine | 4.43 | 20387270 | 
| MESH:D009503 | Neutropenia |  | Cyclophosphamide | 3.71 | 8291058 | 
| MESH:D052556 | Niemann-Pick Disease, Type C |  | Cholesterol | 5.05 | 20557099	9802331 | 
| MESH:D009765 | Obesity |  | Dietary Fats | 6.21 | 21332399	20518802	18674790	20132043	19632207	18457598	11836018	17217161	16723640 | 
| MESH:D009765 | Obesity |  | Fructose | 6.21 | 18585860	17707055 | 
| MESH:D009765 | Obesity |  | pirinixic acid | 6.21 | 20558911 | 
| MESH:D009845 | Oligospermia |  | Cyclophosphamide | 4.04 | 16517039 | 
| MESH:D010003 | Osteoarthritis |  | Iron | 3.53 | 16640825 | 
| MESH:D010018 | Osteomalacia |  | Phenobarbital | 9.85 | 17016548 | 
| MESH:D010018 | Osteomalacia |  | Phenytoin | 9.85 | 17016548 | 
| MESH:D010024 | Osteoporosis |  | Calcium | 6.20 | 17882678 | 
| MESH:D010024 | Osteoporosis |  | Iron | 6.20 | 16648989	16640825 | 
| MESH:D015663 | Osteoporosis, Postmenopausal |  | Quercetin | 8.14 | 19495926 | 
| MESH:D015663 | Osteoporosis, Postmenopausal |  | resveratrol | 8.14 | 17513867 | 
| MESH:D010051 | Ovarian Neoplasms |  | Arsenic | 9.09 | 17306315 | 
| MESH:D010051 | Ovarian Neoplasms |  | Quercetin | 9.09 | 19005980 | 
| MESH:D010051 | Ovarian Neoplasms |  | sodium arsenite | 9.09 | 15276417	17306315 | 
| MESH:D010051 | Ovarian Neoplasms |  | Tretinoin | 9.09 | 16936753 | 
| MESH:D010146 | Pain |  | Acetaminophen | 11.65 | 16870215 | 
| MESH:D010146 | Pain |  | Cyclophosphamide | 11.65 | 18093676	12161096 | 
| MESH:D010146 | Pain |  | Phenytoin | 11.65 | 15215642 | 
| MESH:D010146 | Pain |  | Tretinoin | 11.65 | 16870215 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Cyclophosphamide | 13.14 | 11332152 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Diethylnitrosamine | 13.14 | 16540662 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Phenobarbital | 13.14 | 16965848 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Quercetin | 13.14 | 16965848 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Tretinoin | 13.14 | 15976015 | 
| MESH:D016584 | Panic Disorder |  | Ethinyl Estradiol | 3.06 | 11578682 | 
| MESH:D010212 | Papilloma |  | Iron | 3.84 | 12065085 | 
| MESH:D020447 | Parasomnias |  | Iron | 5.33 | 17352947 | 
| MESH:D010300 | Parkinson Disease |  | Acrolein | 10.01 | 17690948 | 
| MESH:D010300 | Parkinson Disease |  | Cholesterol, Dietary | 10.01 | 19014385 | 
| MESH:D010300 | Parkinson Disease |  | Iron | 10.01 | 16640825	16563566 | 
| MESH:D010300 | Parkinson Disease |  | tolcapone | 10.01 | 11586115	18328768	8739811	10651109	16758261	19578428	7566641	11432539	9708959	11793426	19783845	9333106	9591521	20334432	9305320	17089403	9754991	11746615	1977408	8635184	20216409 | 
| MESH:D020734 | Parkinsonian Disorders |  | Tropicamide | 5.17 | 17594079 | 
| MESH:D010382 | Peliosis Hepatis |  | Tetrachlorodibenzodioxin | 3.56 | 12520081 | 
| MESH:D010523 | Peripheral Nervous System Diseases |  | Arsenic | 3.54 | 16093927 | 
| MESH:D016491 | Peripheral Vascular Diseases |  | Arsenic | 4.32 | 6392382	15371236	16905509 | 
| MESH:D010538 | Peritonitis |  | Ozone | 3.48 | 16369182 | 
| MESH:D010787 | Photosensitivity Disorders |  | Acrolein | 5.05 | 11550810 | 
| MESH:D010900 | Pituitary Diseases |  | Diethylstilbestrol | 11.79 | 14722030 | 
| MESH:D010900 | Pituitary Diseases |  | Iron | 11.79 | 16604332 | 
| MESH:D010911 | Pituitary Neoplasms |  | Diethylstilbestrol | 4.01 | 16977796	15687265 | 
| MESH:D010954 | Plasmacytoma |  | Selenium | 4.20 | 15087411 | 
| MESH:D011014 | Pneumonia |  | Lipopolysaccharides | 8.88 | 11605937	12224865 | 
| MESH:D011014 | Pneumonia |  | Ozone | 8.88 | 18929643	18007984	18381685 | 
| MESH:D011041 | Poisoning |  | Iron | 3.68 | 16604332 | 
| MESH:D017689 | Polydactyly |  | Phenytoin | 4.47 | 9212184 | 
| MESH:D017119 | Porphyria Cutanea Tarda |  | Iron | 8.90 | 16640825 | 
| MESH:D017119 | Porphyria Cutanea Tarda |  | Tetrachlorodibenzodioxin | 8.90 | 18163543 | 
| MESH:D011230 | Precancerous Conditions |  | Cyclosporine | 17.18 | 12371664 | 
| MESH:D011230 | Precancerous Conditions |  | Diethylnitrosamine | 17.18 | 2563599 | 
| MESH:D011230 | Precancerous Conditions |  | Phenobarbital | 17.18 | 2563599 | 
| MESH:D011230 | Precancerous Conditions |  | Quercetin | 17.18 | 19056647 | 
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |  | Cyclophosphamide | 3.39 | 21297632 | 
| MESH:D011225 | Pre-Eclampsia |  | Iron | 3.89 | 16640825 | 
| MESH:D011297 | Prenatal Exposure Delayed Effects |  | Diethylstilbestrol | 12.45 | 17184923 | 
| MESH:D011297 | Prenatal Exposure Delayed Effects |  | resveratrol | 12.45 | 16679765 | 
| MESH:D011297 | Prenatal Exposure Delayed Effects |  | Tetrachlorodibenzodioxin | 12.45 | 11222880	11118676	11399792	11896295 | 
| MESH:D011471 | Prostatic Neoplasms |  | Arsenic | 1.97 | 16140617 | 
| MESH:D011471 | Prostatic Neoplasms |  | Cyclophosphamide | 1.97 | 17136230 | 
| MESH:D011471 | Prostatic Neoplasms |  | Diethylstilbestrol | 1.97 | 15846301	15046698	17136230 | 
| MESH:D011471 | Prostatic Neoplasms |  | Quercetin | 1.97 | 14715546	17292933 | 
| MESH:D011471 | Prostatic Neoplasms |  | resveratrol | 1.97 | 15767336	17804756	16731767	17636462	17718901	17675339 | 
| MESH:D011471 | Prostatic Neoplasms |  | sodium arsenite | 1.97 | 16039940 | 
| MESH:D011471 | Prostatic Neoplasms |  | Tamoxifen | 1.97 | 15067354 | 
| MESH:D020151 | Protein C Deficiency |  | Warfarin | 5.67 | 18376272 | 
| MESH:D011507 | Proteinuria |  | Arsenic | 12.02 | 21343184 | 
| MESH:D011507 | Proteinuria |  | Tretinoin | 12.02 | 16636307 | 
| MESH:D011507 | Proteinuria |  | valsartan | 12.02 | 17664856	18344623	12164870 | 
| MESH:D011528 | Protozoan Infections |  | Iron | 5.33 | 16640825 | 
| MESH:D011537 | Pruritus |  | Ethinyl Estradiol | 2.65 | 15861022	16919318 | 
| MESH:D019310 | Pseudolymphoma |  | Phenobarbital | 10.29 | 12752131 | 
| MESH:D019310 | Pseudolymphoma |  | Phenytoin | 10.29 | 1419762	8603615	12752131 | 
| MESH:D011565 | Psoriasis | marker/mechanism |  |  | 16433808 | 
| MESH:D011565 | Psoriasis |  | Cyclosporine | 1.95 | 16882103 | 
| MESH:D011625 | Pterygium |  | Tretinoin | 4.12 | 16723453 | 
| MESH:D011655 | Pulmonary Embolism |  | Warfarin | 5.67 | 19300499 | 
| MESH:D011658 | Pulmonary Fibrosis |  | Amiodarone | 10.79 | 11597910	12490602	12832656 | 
| MESH:D011658 | Pulmonary Fibrosis |  | Cyclophosphamide | 10.79 | 16636934 | 
| MESH:D011658 | Pulmonary Fibrosis |  | Enalapril | 10.79 | 17265423 | 
| MESH:D011658 | Pulmonary Fibrosis |  | valsartan | 10.79 | 17241526 | 
| MESH:D051437 | Renal Insufficiency |  | Acrolein | 9.10 | 12732208 | 
| MESH:D051437 | Renal Insufficiency |  | Enalapril | 9.10 | 15728788 | 
| MESH:D051436 | Renal Insufficiency, Chronic |  | resveratrol | 4.90 | 16325855 | 
| MESH:D015427 | Reperfusion Injury |  | pirinixic acid | 5.31 | 19058328 | 
| MESH:D015427 | Reperfusion Injury |  | resveratrol | 5.31 | 17520802	16317513	16314181	17058453	15827377 | 
| MESH:D012130 | Respiratory Hypersensitivity |  | Acetylcholine | 6.98 | 9413022 | 
| MESH:D012130 | Respiratory Hypersensitivity |  | Lipopolysaccharides | 6.98 | 10835634 | 
| MESH:D015619 | Respiratory System Abnormalities |  | Tetrachlorodibenzodioxin | 3.20 | 18990726 | 
| MESH:D012148 | Restless Legs Syndrome |  | Iron | 4.02 | 16930377 | 
| MESH:D012208 | Rhabdomyosarcoma |  | Tretinoin | 3.48 | 16116481	16283617 | 
| MESH:D012554 | Schistosomiasis japonica |  | Quercetin | 4.86 | 16862918 | 
| MESH:D012559 | Schizophrenia | marker/mechanism |  |  | 18583979 | 
| MESH:D012595 | Scleroderma, Systemic |  | Cyclophosphamide | 4.20 | 16636934 | 
| MESH:D012618 | Sea-Blue Histiocyte Syndrome | marker/mechanism |  |  |  | 
| MESH:D012640 | Seizures |  | Phenobarbital | 4.80 | 4039156	3137016	11442880	16876388 | 
| MESH:D012640 | Seizures |  | Phenytoin | 4.80 | 19919933	15946322	16876388	11044598	3691417	9844417	10029267	3137016 | 
| MESH:D003294 | Seizures, Febrile |  | Phenobarbital | 4.15 | 6407741 | 
| OMIM:609620 | SHORT QT SYNDROME 1 |  | Amiodarone | 4.41 | 18724381 | 
| MESH:D012852 | Sinusitis |  | Phenylephrine | 4.03 | 7327846 | 
| MESH:D012851 | Sinus Thrombosis, Intracranial |  | Warfarin | 5.21 | 12269725 | 
| MESH:D012871 | Skin Diseases |  | Arsenic | 2.54 | 15952646	19834688	17548696	18709164	17050553	16702368	17453740	6392382	17938729	16353154	16759981 | 
| MESH:D012878 | Skin Neoplasms |  | Arsenic | 21.59 | 19538983	17050553	15504454	16251483	17029826	17976673 | 
| MESH:D012878 | Skin Neoplasms |  | Iron | 21.59 | 12065085 | 
| MESH:D012878 | Skin Neoplasms |  | resveratrol | 21.59 | 15837718	8985016 | 
| MESH:D012878 | Skin Neoplasms |  | sodium arsenite | 21.59 | 19524636	18572023 | 
| MESH:D012878 | Skin Neoplasms |  | tert-Butylhydroperoxide | 21.59 | 8532709 | 
| MESH:D012878 | Skin Neoplasms |  | Tetrachlorodibenzodioxin | 21.59 | 16192470 | 
| MESH:D012878 | Skin Neoplasms |  | Tretinoin | 21.59 | 16467112 | 
| MESH:D013088 | Spermatocele |  | Diethylstilbestrol | 16.19 | 16709447	16002989 | 
| MESH:D013088 | Spermatocele |  | Ethinyl Estradiol | 16.19 | 16709447 | 
| MESH:D013088 | Spermatocele |  | Tamoxifen | 16.19 | 16709447 | 
| OMIM:102530 | SPERMATOGENIC FAILURE 6 |  | Cyclophosphamide | 4.84 | 16517039 | 
| MESH:D013119 | Spinal Cord Injuries |  | Tamoxifen | 3.37 | 19457130 | 
| MESH:D016135 | Spinal Dysraphism |  | sodium arsenite | 3.26 | 12854658 | 
| MESH:D013163 | Splenomegaly | marker/mechanism |  |  |  | 
| MESH:D013262 | Stevens-Johnson Syndrome |  | Phenytoin | 4.50 | 20235791 | 
| MESH:D013274 | Stomach Neoplasms |  | Diethylnitrosamine | 2.92 | 18456281 | 
| MESH:D013274 | Stomach Neoplasms |  | nitrosobenzylmethylamine | 2.92 | 12958204	17575124 | 
| MESH:D013274 | Stomach Neoplasms |  | Tretinoin | 2.92 | 17261132 | 
| MESH:D013276 | Stomach Ulcer |  | Amiodarone | 2.74 | 18087811 | 
| MESH:D020521 | Stroke |  | Acrolein | 7.71 | 16269634 | 
| MESH:D020521 | Stroke |  | Warfarin | 7.71 | 19300499 | 
| OMIM:601367 | STROKE, ISCHEMIC |  | resveratrol | 3.89 | 16321402 | 
| MESH:D013398 | Sudden Infant Death |  | Iron | 4.78 | 16640825 | 
| MESH:D015173 | Supratentorial Neoplasms |  | Cyclophosphamide | 4.39 | 12837982 | 
| MESH:D013610 | Tachycardia |  | Amiodarone | 3.65 | 11238279 | 
| MESH:D017180 | Tachycardia, Ventricular |  | Amiodarone | 3.55 | 19225199 | 
| MESH:D013705 | Temporomandibular Joint Disorders |  | polyphenols | 4.57 | 17997062 | 
| MESH:D013921 | Thrombocytopenia |  | Lipopolysaccharides | 3.58 | 15821434 | 
| MESH:D013923 | Thromboembolism |  | Acenocoumarol | 11.87 | 18698879 | 
| MESH:D013923 | Thromboembolism |  | Warfarin | 11.87 | 16960144	18698879 | 
| MESH:D019851 | Thrombophilia |  | Ethinyl Estradiol | 8.95 | 11994571 | 
| MESH:D019851 | Thrombophilia |  | Warfarin | 8.95 | 17493413 | 
| MESH:D013927 | Thrombosis |  | Ethinyl Estradiol | 7.51 | 15669648 | 
| MESH:D013927 | Thrombosis |  | Warfarin | 7.51 | 11518727	17245631	11307788	15720958	17672075	19300499 | 
| MESH:D013959 | Thyroid Diseases |  | Amiodarone | 9.78 | 19731979 | 
| MESH:D013959 | Thyroid Diseases |  | Tetrachlorodibenzodioxin | 9.78 | 12697716 | 
| MESH:D013964 | Thyroid Neoplasms |  | Diethylnitrosamine | 8.93 | 7505956 | 
| MESH:D013964 | Thyroid Neoplasms |  | Phenobarbital | 8.93 | 1399818 | 
| MESH:D013964 | Thyroid Neoplasms |  | Tretinoin | 8.93 | 16026305	17045167 | 
| MESH:D013971 | Thyrotoxicosis |  | Amiodarone | 4.20 | 18020914	19584973 | 
| MESH:D014062 | Tongue Neoplasms |  | resveratrol | 7.95 | 16227395 | 
| MESH:D014062 | Tongue Neoplasms |  | Tretinoin | 7.95 | 16051514 | 
| MESH:D016171 | Torsades de Pointes |  | Amiodarone | 3.52 | 11989578	17467628 | 
| MESH:D014202 | Tremor |  | Tropicamide | 5.52 | 17594079	19467297 | 
| MESH:D014376 | Tuberculosis |  | Iron | 6.67 | 16597321 | 
| MESH:D014376 | Tuberculosis |  | Tretinoin | 6.67 | 16040207 | 
| MESH:D018088 | Tuberculosis, Multidrug-Resistant |  | tolcapone | 5.26 | 19578428 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Arsenic | 15.74 | 19429237	17976673	18640142	15987713	17306315	19322015	11144890 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Cyclophosphamide | 15.74 | 14692829 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Diethylstilbestrol | 15.74 | 16712894	16452187	17306315 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Quercetin | 15.74 | 16720314 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | sodium arsenite | 15.74 | 16712894	17306315	11723127	16452187 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Tamoxifen | 15.74 | 17572228	8653321	16712894 | 
| MESH:D014570 | Urologic Diseases |  | cypermethrin | 5.18 | 16487989 | 
| MESH:D014581 | Urticaria |  | Acetaminophen | 2.36 | 10982225 | 
| MESH:D002583 | Uterine Cervical Neoplasms |  | Diethylstilbestrol | 17.82 | 16175088 | 
| MESH:D002583 | Uterine Cervical Neoplasms |  | resveratrol | 17.82 | 17473185 | 
| MESH:D002583 | Uterine Cervical Neoplasms |  | sodium arsenite | 17.82 | 11813266 | 
| MESH:D002583 | Uterine Cervical Neoplasms |  | Tretinoin | 17.82 | 16129372 | 
| MESH:D014591 | Uterine Diseases |  | Diethylstilbestrol | 4.48 | 14652134 | 
| MESH:D014594 | Uterine Neoplasms |  | Diethylstilbestrol | 12.39 | 16690809	15809267 | 
| MESH:D014594 | Uterine Neoplasms |  | Ethinyl Estradiol | 12.39 | 14692618 | 
| MESH:D014594 | Uterine Neoplasms |  | resveratrol | 12.39 | 17044934 | 
| MESH:D014604 | Uveal Neoplasms |  | Tretinoin | 3.93 | 16752155 | 
| MESH:D014605 | Uveitis |  | Cyclosporine | 3.30 | 1336536 | 
| MESH:D014625 | Vaginal Neoplasms |  | Diethylstilbestrol | 3.78 | 16513791	16002989 | 
| MESH:D014652 | Vascular Diseases |  | Arsenic | 9.62 | 17056641 | 
| MESH:D014652 | Vascular Diseases |  | sodium arsenite | 9.62 | 17056641 | 
| MESH:D054079 | Vascular Malformations |  | Tetrachlorodibenzodioxin | 3.91 | 12125929 | 
| MESH:D014657 | Vasculitis |  | Warfarin | 5.21 | 20337814 | 
| MESH:D054556 | Venous Thromboembolism |  | Warfarin | 5.68 | 18776969 | 
| MESH:D020246 | Venous Thrombosis |  | Ethinyl Estradiol | 8.73 | 14671159	15869587 | 
| MESH:D020246 | Venous Thrombosis |  | Warfarin | 8.73 | 14723717	15733061 | 
| MESH:D018487 | Ventricular Dysfunction, Left |  | resveratrol | 3.65 | 17488730 | 
| MESH:D020257 | Ventricular Remodeling |  | valsartan | 5.03 | 19027736 | 
| MESH:D014820 | Vitiligo |  | tolcapone | 8.97 | 10573327 | 
| MESH:D014820 | Vitiligo |  | Tretinoin | 8.97 | 16761959 | 
| MESH:D019282 | Wasting Syndrome |  | Tetrachlorodibenzodioxin | 3.56 | 15886252 | 
| MESH:D015430 | Weight Gain |  | Dietary Fats | 3.16 | 16723640 | 
| MESH:D009396 | Wilms Tumor |  | Tretinoin | 3.39 | 16287080 | 
| MESH:D014985 | Xerophthalmia |  | Cyclosporine | 3.76 | 17120751 |